Tuesday, September 17, 2013

Mother to Offspring Transmission of Transmissible Spongiform Encephalopathy TSE prion disease

Mother to Offspring Transmission of Chronic Wasting Disease in Reeves’ Muntjac Deer

 

Amy V. Nalls1, Erin McNulty1, Jenny Powers2, Davis M. Seelig3, Clare Hoover1, Nicholas J. Haley1, Jeanette Hayes-Klug1, Kelly Anderson1, Paula Stewart4, Wilfred Goldmann4, Edward A. Hoover1, Candace K. Mathiason1*

 

1 Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, United States of America, 2 Biological Resource Management Division, National Park Service, Fort Collins, Colorado, United States of America, 3 Department of Veterinary Clinical Sciences, University of Minnesota, Saint Paul, Minnesota, United States of America, 4 The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, Scotland, United Kingdom

 

Abstract

 

The horizontal transmission of prion diseases has been well characterized in bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) of deer and elk and scrapie of sheep, and has been regarded as the primary mode of transmission. Few studies have monitored the possibility of vertical transmission occurring within an infected mother during pregnancy. To study the potential for and pathway of vertical transmission of CWD in the native cervid species, we used a small cervid model–the polyestrous breeding, indoor maintainable, Reeves’ muntjac deer–and determined that the susceptibility and pathogenesis of CWD in these deer reproduce that in native mule and white-tailed deer. Moreover, we demonstrate here that CWD prions are transmitted from doe to fawn. Maternal CWD infection also appears to result in lower percentage of live birth offspring. In addition, evolving evidence from protein misfolding cyclic amplification (PMCA) assays on fetal tissues suggest that covert prion infection occurs in utero. Overall, our findings demonstrate that transmission of prions from mother to offspring can occur, and may be underestimated for all prion diseases.

 

Introduction Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal neurodegenerative diseases that affect a variety of species, including humans (Kuru; variant Creutzfeldt-Jakob disease [vCJD]), cattle (bovine spongiform encephalopathy [BSE]), sheep (scrapie), mink (transmissible mink encephalopathy [TME]), domestic and nondomestic cats (feline spongiform encephalopathy [FSE]) and cervids (chronic wasting disease [CWD]).

 

The transmission of prions, while remaining poorly understood, has obvious public health significance and requires sustained re-appraisal of present concepts for both TSE spread and intervention strategies. It is clear that TSEs are spread by horizontal means of transmission via oral ingestion (Kuru, BSE, vCJD, TME, FSE, CWD) and environmental (scrapie, CWD) contact with infectious prions, as well as by medical means including blood transfusion (vCJD, CWD, scrapie), or iatrogenic exposure (vCJD, sCJD). While less studied, supporting evidence has emerged for an additional path of transmission– that from mother to offspring.

 

A variant form of the human prion disease CJD, known as variant CJD (vCJD), was attributed to the ingestion of BSE-infected meat products [1], [2]. It is known that vCJD can be transmitted from human to human via blood transfusion from both symptomatic and asymptomatic donors [3]–[6] and that a prolonged asymptomatic incubation period occurs in 129 Met/Val individuals [7]. It is estimated that up to 1 in 4,000 individuals in the UK are asymptomatic carriers of vCJD [8]–[10].

 

To date, 125 children have been born to women who later developed CJD [11]. This is concerning because PrPCJD has been detected in the fetal and pregnancy related tissues of a woman infected with CJD [12]. Although decades may pass before the onset of clinical effects associated with such transmission due to a long subclinical carrier state, the probability that these individuals harbor infectious prions remains high.

 

Animal TSEs suggest similar disease patterns. Scrapie prions have been detected in maternal and fetal sheep tissues [13]–[22], and there is a higher incidence of clinical disease during the lambing season [14], [23]–[27]. It is known that BSE incidence is higher in calves born to BSE-infected cattle [28], [29] and that BSE has been transmitted to the offspring of BSE-infected female mice expressing bovid PrP [30]. A cheetah cub, born to a FSE-infected cheetah, was housed in a TSE-free environment and fed a TSE-free diet, yet succumbed to FSE at 7 years of age [31], suggesting maternal exposure.

 

Importantly, infectious prions are present in the brain, bodily fluids and excreta of animals showing no clinical signs of TSE [32]–[37]. For example, the blood, saliva and urine from deer subclinically infected with CWD contain infectious prions [32], [38], [39]. Race and coworkers [40] found a long-term subclinical carrier state in mice infected with hamster scrapie. Atypical BSE (BASE) can be transmitted from non-clinical cattle to primates [41] and cattle exposed to large oral doses of BSE can remain free of clinical signs but are found to harbor infectious prions upon bioassay into bovid PrP transgenic mice [42]. Taken together, these findings suggest that carriers without clinical signs exist and may transmit infection to their offspring via milk, transplacental trafficking or blood.

 

Chronic wasting disease, known for its efficient transmission among cervids, is now recognized in 22 states, two Canadian provinces and South Korea (http://www.nwhc.usgs.gov/disease_informa​tion/chronic_wasting_disease/index.jsp). Studies proved that CWD can be horizontally transmitted among cervids either by direct contact with infected animals [43], their secreta [32], [33], [38], [44] or indirectly through the environment they inhabit [39], [45]. As observed in other animal TSEs, even cervids in the subclinical phase of disease harbor transmissible infectious prions [32], [39], [46]–[49]. Although there is a growing body of evidence that identifies the sources of infectious prions, less defined are the mechanisms by which prions are shed by infected hosts and taken up by their naïve counterparts. One such mechanism may include that from mother to offspring, either in utero (vertical transmission), or shortly after birth in colostrum or milk (maternal transmission).

 

To address the possibility of CWD mother to offspring transmission we utilized Reeves’ muntjac deer (Muntiacus reevesi) [50]. This small Asian deer reaches sexual maturity at 6 months of age, is polyestrous, and can be bred and housed conveniently in indoor controlled laboratory conditions, thus providing a suitable in vivo model for cervid vertical/maternal transmission studies [51].

 

We undertook this study to determine: 1) whether Reeves’ muntjac deer are susceptible to CWD, 2) whether CWD is transmitted from mother to offspring, and 3) whether offspring born to CWD-infected mothers develop clinical TSE disease.

 

 

snip...

 

 

Implications Associated with Transmission of CWD to Offspring

 

The facile transmission of CWD seen in herds of free ranging and captive cervids has led to questions regarding the modes of transmission. While direct contact with infected cervids, as well as indirect contact with infectious bodily fluids and contaminated environments are suspected to account for much of this transmission, a third path of transmission, the one from mother to offspring, may be underappreciated. PrPCWD placental accumulation and CWD in utero acquirement would help explain the surprisingly high rates of CWD among cervids. Moreover, CWD positive nonviable offspring carcasses 1) would contribute to environmental prion contamination [77] and 2) would be available for consumption by scavenger species, thus increasing the potential for cross-species transmission [53,78,79]. Viable offspring may spread disease by 1) direct cervid-to-cervid contact, 2) multigenerational mother to offspring transmission, as well as 3) shedding infectious prions in bodily secretions (urine, feces, saliva, blood) during their entire lifespan.

 

Here, in an experimental model of CWD, we have demonstrated the transmission of infectious prions from clinical and subclinical mothers to full-term viable, nonviable and in utero harvested offspring, revealing that the transmission of TSEs from mother to offspring can occur and may be underestimated for all prion diseases.

 

 

 

Citation: Nalls AV, McNulty E, Powers J, Seelig DM, Hoover C, et al. (2013) Mother to Offspring Transmission of Chronic Wasting Disease in Reeves’ Muntjac Deer. PLoS ONE 8(8): e71844. doi:10.1371/journal.pone.0071844

 

Editor: Ilia V. Baskakov, University of Maryland School of Medicine, United States of America Received May 1, 2013; Accepted July 3, 2013; Published August 14, 2013

 

Copyright: 2013 Nalls et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Funding: This work was supported by NIH grants N01-AI-25491 and R01-AI-093634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

 

Competing Interests: The authors have declared that no competing interests exist. * E-mail: Candace.Mathiason@colostate.edu

 

snip...

 

 

 


 

 

 

Sunday, August 25, 2013

 

Prion2013 Chronic Wasting Disease CWD risk factors, humans, domestic cats, blood, and mother to offspring transmission

 

snip...

 

Oral.08: Mother to offspring transmission of chronic wasting disease in Reeve's Muntjac deer Amy Nalls,1 Erin McNulty,1 Jenny Powers,2 Davis Seelig,1 Clare Hoover,1 Nicholas Haley,1 Jeanette Hayes-Klug,1 Kelly Anderson,1 Paula Stewart,3 Wilfred Goldmann,3 Edward A. Hoover1 and Candace K. Mathiason1 1Colorado State University; Fort Collins, CO USA; 2National Park Service; Fort Collins, CO USA; 3The Roslin Institute and Royal School of Veterinary Studies; Edinburgh, UK To investigate the role mother to offspring transmission plays in chronic wasting disease (CWD), we have developed a cervid model employing the Reeve's muntjac deer (Muntiacus reevesi). Eight muntjac doe were orally inoculated with CWD and tested PrPCWD lymphoid positive by 4 mo post infection. Fourteen fawns were born to these eight CWD-infected doe-3 were born viable, 6 were born non-viable and 5 were harvested as fetuses from early or end-stage CWD-infected doe. All three viable fawns have demonstrated CWD IHC lymphoid biopsy positivity between 43 d post birth and 11 mo post birth. Two of these three CWD positive viable offspring have developed clinical signs consistent with TSE disease (28-33 mo post birth). Moreover, CWD prions have been detected by sPMCA in 11 of 16 tissues harvested from 6 full-term non-viable fawns and in 7 of 11 fetal tissues harvested in utero from the second and third trimester fetuses. Additional tissues and pregnancy related fluids from doe and offspring are being analyzed for CWD prions. In summary, using the muntjac deer model we have demonstrated CWD clinical disease in offspring born to CWD-infected doe, and in utero transmission of CWD from mother to offspring. These studies provide basis to further investigate the mechanisms of maternal transfer of prions.

 

 

snip...

 

 

Sunday, August 25, 2013

 

Prion2013 Chronic Wasting Disease CWD risk factors, humans, domestic cats, blood, and mother to offspring transmission

 


 

 

 

>>> Here, in an experimental model of CWD, we have demonstrated the transmission of infectious prions from clinical and subclinical mothers to full-term viable, nonviable and in utero harvested offspring, revealing that the transmission of TSEs from mother to offspring can occur and may be underestimated for all prion diseases. <<<

 

 

 

 

 

EFSA Journal 2013;11(2):3080

 

Suggested citation: EFSA Panel on Biological Hazards (BIOHAZ); Scientific Opinion on the risk of transmission of classical

 

scrapie via in vivo derived embryo transfer in ovine animals. EFSA Journal 2013;11(2):3080. [15 pp.]

 

doi:10.2903/j.efsa.2013.3080. Available online: www.efsa.europa.eu/efsajournal

 

© European Food Safety Authority, 2013

 

SCIENTIFIC OPINION

 

Scientific Opinion on the risk of transmission of classical scrapie via in vivo derived embryo transfer in ovine animals1

 

EFSA Panel on Biological Hazards2, 3

 

European Food Safety Authority (EFSA), Parma, Italy

 

ABSTRACT

 

The risk of transmission of classical scrapie via the transfer of in vivo derived embryo in ovines was assessed, taking into account the scientific information made available since the last EFSA opinion on this topic (2010) (see http://www.efsa.europa.eu/en/efsajournal/pub/1429.htm). The potential impact of PrP genotype of the embryo and/or of the ram and donor ewe on this risk was also assessed. The new data made available over the last three years further reinforce the view that classical scrapie could be vertically transmitted in sheep. Since the possibility of such vertical transmission was already considered in the previous opinion, its conclusions and recommendations relating to the risk of classical scrapie transmission via embryo transfer remain valid. In ovines, the susceptibility to classical scrapie infection in sheep is strongly influenced by certain polymorphisms of the PrP gene. Under natural exposure conditions, animals that are heterozygous or homozygous A136R154R171 display respectively a low or negligible risk of being infected. The genetic control of the susceptibility to classical scrapie is also likely to impact on the risk of transmitting the disease via embryo transfer. Irrespective of the embryo’s genotype, embryos derived from rams and dams carrying at least one ARR allele would significantly decrease this risk (compared to an embryo from parents of unknown genotypes). The use of homozygous ARR embryos would provide the highest level of safety regarding the risk of transmitting classical scrapie through embryo transfer (in vivo derived embryos). The use of heterozygous ARR embryos would ensure a higher level of safety compared to Q171/Q171 embryos. Finally, it was concluded that, providing the OIE recommendations and procedures relating to embryo transfer are adhered to, the risk of transmitting classical scrapie due to the transfer of homozygous or heterozygous ovine ARR embryos can be considered negligible.

 

© European Food Safety Authority, 2013

 

KEY WORDS

 

Classical scrapie, ovine, sheep, embryo transfer, transmission risk

 

1 On request from the European Commission, Question No EFSA-Q-2012-00647, adopted on 24 January 2013.

 

2 Panel members: Olivier Andreoletti, Dorte Lau Baggesen, Declan Bolton, Patrick Butaye, Paul Cook, Robert Davies, Pablo S. Fernandez Escamez, John Griffin, Tine Hald, Arie Havelaar, Kostas Koutsoumanis, Roland Lindqvist, James McLauchlin, Truls Nesbakken, Miguel Prieto Maradona, Antonia Ricci, Giuseppe Ru, Moez Sanaa, Marion Simmons, John Sofos and John Threlfall. One member of the Panel did not participate in the discussion on the subject referred to above because of potential conflicts of interest identified in accordance with the EFSA policy on declarations of interests. Correspondence: biohaz@efsa.europa.eu

 

3 Acknowledgement: The Panel wishes to thank the members of the Working Group on the risk of transmission of classical scrapie via in vivo embryo transfer in ovine animals: Olivier Andreoletti, Nora Hunter and Ciriaco Ligios for the preparatory work on this scientific opinion and the hearing experts: Michel Thibier and Pascale Chavatte-Palmer, and EFSA staff: Pablo Romero Barrios for the support provided to this scientific opinion.

 

 

 

snip...

 

 

CONCLUSIONS AND RECOMMENDATIONS

 

CONCLUSIONS Since the 2010 opinion only two relevant studies have been published. None of them suggest a need to revise the previous conclusion adopted by the BIOHAZ Panel in January 2010 i.e ‘Based on the data currently available the risk of TSE transmission associated with embryos collected from Classical scrapie incubating ewes and she-goats ranges from negligible to low. However, data are insufficient to conclude that such a risk is negligible.’ In sheep the susceptibility to classical scrapie infection is strongly influenced by the polymorphisms of the PrP gene. Under natural exposure conditions, animals that are heterozygous or homozygous ARR show respectively a low or negligible risk of being infected by classical scrapie. This genetic control of the susceptibility to classical scrapie infection directly influences the risk of transmitting the disease via embryo transfer:

 

– Irrespective of the embryo’s genotype, the use of embryos derived from rams and dams carrying at least one ARR allele would significantly decrease the risk of transmitting classical scrapie via embryo transfer (by comparison to an embryo from parents of unknown genotypes).

 

– The use of homozygous ARR embryos would provide the highest possible level of safety with regard to the risk of transmitting classical scrapie through embryo transfer (in vivo derived embryos).

 

– The use of heterozygous ARR embryos would ensure a higher level of safety by comparison with Q171/Q17110 embryos.

 

– The risk of transmitting classical scrapie by implantation of a Q171/Q171 embryo collected from a dam with an unknown classical scrapie status cannot be considered negligible. Providing that the OIE recommendations and procedures relating to embryo transfer are adhered to, the risk of transmitting classical scrapie by the implantation of homozygous or heterozygous ovine ARR embryos can be considered negligible.

 

 

RECOMMENDATIONS The recommendations relating to the risk of transmitting classical scrapie via embryo transfer that were formulated in the 2010 opinion remain valid. In particular, the presence of infectivity in ovine embryos collected from scrapie infected dams bearing susceptible genotypes needs to be assessed before a definitive assessment of the risk of transmitting classical scrapie via the use of embryos bearing a susceptible genotype can be made.

 

 

10 By convention Q171 refers to ARQ, VRQ, and AHQ alleles.

 

 


 

 

 

 

>>>Finally, it was concluded that, providing the OIE recommendations and procedures relating to embryo transfer are adhered to, the risk of transmitting classical scrapie due to the transfer of homozygous or heterozygous ovine ARR embryos can be considered negligible.<<<

 

 

 

 

 

‘’LOL’’ !  ...tss

 

 

 

 

 

Tuesday, April 30, 2013

 

Transmission of classical scrapie via goat milk

 

Veterinary Record2013;172:455 doi:10.1136/vr.f2613

 


 

 

 

Friday, May 10, 2013

 

Evidence of effective scrapie transmission via colostrum and milk in sheep

 


 

 

 

 

Thursday, April 26, 2012

 

Maternal Transmission of the BSE and Birth Cohorts

 


 

 

 

 

December 14, 2011

 

 

Detection of PrPres in Genetically Susceptible Fetuses from Sheep with Natural Scrapie

 

María Carmen Garza1, Natalia Fernández-Borges2, Rosa Bolea1, Juan José Badiola1, Joaquín Castilla2,3, Eva Monleón1,4*

 

1 Centro de Investigación en Encefalopatías Espongiformes Transmisibles y Enfermedades Emergentes, Universidad de Zaragoza, Zaragoza, Spain, 2 CIC bioGUNE, Parque Tecnológico de Bizkaia, Derio, Spain, 3 IKERBASQUE, Basque Foundation for Science, Bilbao, Spain, 4 Producció Animal, Universitat de Lleida, LLeida, Spain

 

 Scrapie is a transmissible spongiform encephalopathy with a wide PrPres dissemination in many non-neural tissues and with high levels of transmissibility within susceptible populations. Mechanisms of transmission are incompletely understood. It is generally assumed that it is horizontally transmitted by direct contact between animals or indirectly through the environment, where scrapie can remain infectious for years. In contrast, in utero vertical transmission has never been demonstrated and has rarely been studied. Recently, the use of the protein misfolding cyclic amplification technique (PMCA) has allowed prion detection in various tissues and excretions in which PrPres levels have been undetectable by traditional assays. The main goal of this study was to detect PrPres in fetal tissues and the amniotic fluid from natural scrapie infected ewes using the PMCA technique. Six fetuses from three infected pregnant ewes in an advanced clinical stage of the disease were included in the study. From each fetus, amniotic fluid, brain, spleen, ileo-cecal valve and retropharyngeal lymph node samples were collected and analyzed using Western blotting and PMCA. Although all samples were negative using Western blotting, PrPres was detected after in vitro amplification. Our results represent the first time the biochemical detection of prions in fetal tissues, suggesting that the in utero transmission of scrapie in natural infected sheep might be possible.

 

 

 

Citation: Garza MC, Fernández-Borges N, Bolea R, Badiola JJ, Castilla J, et al. (2011)

 

 

Detection of PrPres in Genetically Susceptible Fetuses from Sheep with Natural Scrapie.

 

 

PLoS ONE 6(12): e27525. doi:10.1371/journal.pone.0027525

 

Editor: Jason Bartz, Creighton University, United States of America

 

Received: July 20, 2011; Accepted: October 18, 2011; Published: December 14, 2011

 

Copyright: © 2011 Garza et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Funding: This study was supported by a national grant from Spain (AGL2009-11553-C02-01), a Basque government grant (PI2010-18) and the Department of Industry, Tourism and Trade of the Government of the Autonomous Community of the Basque Country (Etortek Research Programs 2011/2013), from the Innovation Technology Department of the Bizkaia County. Dr. Garza was supported by a FPU doctoral grant from the Spanish Ministry of Education (AP2007-03842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

 

Competing interests: The authors have declared that no competing interests exist.

 

* E-mail: emonleon@unizar.es

 

 


 

 

 

SEMEN AND TSE INFECTIVITY

 

Saturday, February 11, 2012

 

PrPSc Detection and Infectivity in Semen from Scrapie-Infected Sheep

 


 

 

 

Envt.18: Mother to Offspring Transmission of Chronic Wasting Disease

 

Candace K. Mathiason,† Amy Nalls, Kelly Anderson, Jeanette Hayes-Klug, Jenny G. Powers, Nicholas J. Haley and Edward A. Hoover

 

Colorado State University; Fort Collins, CO USA†Presenting author; Email: ckm@lamar.colostate.edu

 

We have developed a new cervid model in small Asian muntjac deer (Muntiacus reevesi) to study potential modes of vertical transmission of chronic wasting disease (CWD) from mother to offspring. Eight of eight (8/8) muntjac doe orally infected with CWD tested PrPCWD lymphoid positive by four months post infection. Ten fawns were born to these CWD-infected doe— four of the fawns were viable, five were non-viable and one was a first trimester fetus harvested from a CWD-infected doe euthanized at end-stage disease. The viable fawns have been monitored for CWD infection by immunohistochemistry and sPMCA performed on serial tonsil and rectal lymphoid tissue biopsies. PrPCWD has been detected in one fawn by IHC as early as 40 days of age. Moreover, sPMCA performed on rectal lymphoid tissue has yielded positive results on another fawn at ten days of age. In addition, sPMCA assays have demonstrated amplifiable prions in fetal placental or spleen tissue of three non-viable fawns and mammary tissue of the dams.

 

Additional pregnancy related fluids and tissues from the doe as well as tissue from the nonviable fawns are currently being probed for the presence of CWD. In summary, we have employed the muntjac deer model, to demonstrate for the first time the transmission of CWD from mother to offspring. These studies provide the foundation to investigate the mechanisms and pathways of maternal prion transfer.

 

 

===========================

 

 

***PPo3-18: A Possible Case of Maternal Transmission of the BSE Agent within Captive Cheetah Affected with Feline Spongiform Encephalopathy

 

Anna Bencsik, Sabine Debeer, Thierry Petit and Thierry Baron

 

Afssa; Unité ATNC; Lyon, France; Zoo de la Palmyre; Les Mathes, France

 

Key words: BSE, FSE, vertical transmission

 

Introduction. Feline spongiform encephalopathy (FSE) is considered to be related to bovine spongiform encephalopathy (BSE). It has been reported in domestic cats as well as in captive wild cats including cheetahs, first in the United Kingdom (UK) and then in other European countries. In France, several cases were described in cheetahs either imported from UK or born in France. Here we report details of two other FSE cases in captive cheetah. These cases are of particular interest since the 2nd case of FSE in a cheetah born in France, appears most likely due to maternal transmission.1

 

Results. Complete PrPd study showed the close likeness between the two cheetah cases. The TgOvPrP4 mouse brains infected with cattle BSE and cheetah FSE revealed similar vacuolar lesion profiles, PrPd brain mapping with occurrence of typical florid plaques.

 

Materials and Methods. Using immunohistochemistry (IHC), pathological form of PrP(PrPd) was analyzed in the brains and peripheral organs of these two cheetahs. Transmission studies to the TgOvPrP4 mouse line were also performed, for comparison with the transmission of cattle BSE. Lesion profiles of the infected transgenic mice were analyzed as well as type and brain distribution of PrPd.

 

Conclusion. Collectively, these data indicate that both FSE cases harbor the same strain of agent as the cattle BSE agent. Because this is most probably a case of maternal transmission of the disease, this new observation may have some impact on our knowledge of vertical transmission of BSE agent-linked TSEs such as in human variant Creutzfeldt Jakob disease.

 

References

 

 

1. Bencsik et al. PLoS One 2009; 4:6929.

 

 

=========================

 

 

PPo3-40: Mother to Offspring Transmission of Chronic Wasting Disease

 

Candace K. Mathiason, Amy V. Nalls, Kelly Anderson, Jeanette Hayes-Klug, Nicholas Haley and Edward A. Hoover

 

Colorado State University, Department of Microbiology, Immunology and Pathology, Fort Collins, CO USA

 

Key words: Chronic wasting disease, vertical transmission, muntjac deer

 

We have developed a new cervid model in small Asian muntjac deer (Muntiacus reevesi) to study potential modes of vertical transmission of chronic wasting disease (CWD) from mother to offspring. Eight of eight (8/8) muntjac doe orally infected with CWD tested PrPCWD lymphoid positive by 4 months post infection. Six fawns were born to these CWD-infected doe. Six fawns were born to 6 CWD-infected doe; 4 of the fawns were non-viable. The viable fawns have been monitored for CWD infection by immunohistochemistry and sPMCA performed on serial tonsil and rectal lymphoid tissue biopsies. PrPCWD has been detected in one fawn as early as 40 days of age. Moreover, sPMCA performed on rectal lymphoid tissue has yield positive results on another fawn at 10 days of age. In addition, sPMCA assays have also demonstrated amplifiable prions in maternal placental (caruncule) and mammary tissue of the dam.

 

Additional pregnancy related fluids and tissues from the doe as well as tissue from the nonviable fawns are currently being probed for the presence of CWD. In summary, we have employed the muntjac deer model, to demonstrate for the first time the transmission of CWD from mother to offspring. These studies provide the foundation to investigate the mechanisms and pathways of maternal prion transfer.

 

 

 

PRION 2011

 

landesbioscience.com

 

 

 

International Prion Congress: From agent to diseaseSeptember 8–11, 2010Salzburg, Austria

 

 


 

 

 

 

PRION 2010

 

 


 

 


 

 

 

Wednesday, December 30, 2009

 

Is there evidence of vertical transmission of variant CJD ?

 

J Neurol Neurosurg Psychiatry doi:10.1136/jnnp.2009.172148

 


 

 

 

Monday, November 22, 2010

 

SHEEP WITH MASTITIS TRANSMIT INFECTIOUS PRIONS THROUGH THE MILK

 


 

 

 

Monday, November 22, 2010

 

SHEEP WITH MASTITIS TRANSMIT INFECTIOUS PRIONS THROUGH THE MILK

 

J. Virol. doi:10.1128/JVI.02022-10 Copyright (c) 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

 


 

 

 

Saturday, December 3, 2011

 

Isolation of Prion with BSE Properties from Farmed Goat

 

Volume 17, Number 12—December 2011

 


 

 

 

Prion disease spreads in sheep via mother's milk

 

communicated by: Terry S Singeltary Sr [ These research confirms experimentally previous observations by others (such as, Lacroux C et al: Prions in Milk from Ewes Incubating Natural Scrapie. PLoS Pathog 4(12): e1000238.doi:10.1371/journal.ppat.1000238;

 

 


 

 


 

 

 

SNIP...

 

 


 

 

 

-------- Original Message --------

 

Subject: POSITION STATEMENT MATERNAL TRANSMISSION OF vCJD SEAC

 

Date: Fri, 04 Feb 2005 09:54:58 –0600

 

From: "Terry S. Singeltary Sr."

 

To: Bovine Spongiform Encephalopathy

 

CC: cjdvoice@yahoogroups.com, Agriculture@mail.house.gov

 

1

 

POSITION STATEMENT MATERNAL TRANSMISSION OF vCJD

 

 Issue

 

 1. The Chief Medical Officer for England asked SEAC to consider current evidence and comment on the potential transmission of vCJD from mother to child via human breast milk. In utero transmission was also considered. The committee also commented on the scientific basis of a risk reduction measure for possible transmission of vCJD via banked breast milk.

 

 Background

 

 2. No diagnostic test is currently available for the detection of abnormal PrP in milk. Research is under way to develop tests to screen for the possible presence of abnormal prion protein (PrP) in milk samples from cattle experimentally infected with BSE1. These modified tests may also be applicable to human milk. However, it is not yet clear when/if a reliable test will be available.

 

 3. A small number of breast milk banks in the UK supply highly vulnerable premature babies for whom no milk may be available from the mother. A model developed by the Department of Health to assess the effect of pooling breast milk from multiple donors on the possible risks of transmission of vCJD via breast milk banks was considered.

 

 4. There is some, albeit limited, published epidemiological and experimental research on maternal transmission of prion diseases. There are also unpublished surveillance data of children born to vCJD cases from the National CJD Surveillance Unit and UK surveillance of neurological illness in children which might inform on potential risks of maternal transmission.

 

 1 A joint FSA/SEAC milk working group is monitoring and providing advice on this research carried out at the Veterinary Laboratories Agency.

 

 2 Breast milk banks

 

 5. There is no evidence that vCJD infectivity has ever been transmitted through breast milk. However, a theoretical risk exists. Modelling studies clearly show that the practice of pooling breast milk increases the number of donors to which a recipient is exposed and thereby increases the potential risk of an infant receiving milk contaminated with vCJD infectivity. The theoretical risk of infection can be minimised by not pooling the milk, by the use of individual hand operated breast milk pumps for single donors, and by the use of single-use sterilised bottles for collection. In addition, available evidence suggests that infection/inflammation of the breast results in increased lymphocytes in milk and therefore increased risk of infectivity. This risk would be minimised if milk from donors showing signs of infection is not used.

 

 6. The committee suggested that, if practicable, milk could be stored for an appropriate period of time to allow the health status of donors to be monitored, before it is released. However, information was not available to the committee on whether long-term storage of human milk is detrimental to its nutritional quality.

 

 Maternal transmission

 

 7. There is evidence from animal studies for low level maternal transmission of prions in cattle and sheep. This transmission may occur in utero, via milk and/or perinatally. However, the possibility that this putative maternal transmission might have been due to another mode of transmission, for example through a contaminated environment or feed, cannot be ruled out.

 

 8. In contrast, in humans there is no evidence for maternal transmission in cases of familial prion disease, other than the transfer of a mutant form of the PrP gene, and there is no evidence of maternal transmission of Kuru. However, compared with other human prion diseases vCJD may pose a greater risk because of the greater involvement of the lymphoreticular system in vCJD pathogenesis. Although, breast tissue (and placenta) from a single vCJD case tested negative for PrPvCJD, transfer of infectivity to breast milk may depend on the physiological status of the mammary gland. Similar tests or infectivity bioassays have not been conducted on breast tissue from lactating patients with vCJD. 3

 

 9. A published study suggesting transmission of sCJD in colostrum2 was considered unreliable because tissues not normally associated with high levels of infectivity (blood and placenta) showed equivalent infectivity to that of the brain in this study.

 

 10. Analysis of prospective surveillance data of UK children born to mothers with, or that had subsequently developed clinical vCJD, provide no evidence for maternal transmission of vCJD. However, the number of cases is very small and the incubation period of vCJD, if transmitted from mother to child, is unknown and so the children may yet be too young to have developed symptoms.

 

 11. The phenotype of BSE infection in humans expressing PrP genotypes other than M/M at codon 129 is not known. Given recently published studies in mice expressing the human PrP gene3, which suggest that the human PrP genotype may affect disease phenotype, the committee considered it very important that undiagnosed neurological diseases be carefully monitored. In this respect, amongst others, it is recommended that the careful monitoring of neurological illnesses through the PIND surveillance of children4 continue.

 

 Conclusions

 

 12. In summary, there is currently no epidemiological evidence for maternal transmission of vCJD, including transmission via breast milk. However, there is a hypothetical risk. Although available evidence is limited and mostly indirect rather than direct, this risk, if any, appears to be low. As a risk cannot be excluded, a watching brief should be maintained.

 

 SEAC

 

 January 2005

 

 2 Tamai Y et al. Demonstration of the transmissible agent in tissue from a pregnant woman with CJD. New Eng J Med 1992 327, 649.

 

 3 Wadsworth et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science. 2004 306, 1793-1796.

 

 4 Devereux G et al. Variations in neurodegenerative disease across the UK: findings from the national study of Progressive Intellectual and Neurological Deterioration (PIND). Arch Dis Child. 2004 89, 8-12.

 


 

 

Date: Thu 20 Jan 2005

 

From: Terry S. Singeltary Sr.

 

 

Chronic Lymphocytic Inflammation Specifies the Organ Tropism of Prions

 

 ----------------------------------------------------------------------[

 

 The following is the summary of a paper by Mathias Heikenwalder and 8 others, published in Science online, 10.1126/science.1106460, Thu 20 Jan 2005

 


 

This paper describes work that illustrates that chronic inflammatory conditions may affect and expand the natural and iatrogenic transmission of prions - Mod.CP]Prions typically accumulate in nervous and lymphoid tissues. Because proinflammatory cytokines and immune cells are required for lymphoid prion replication, we tested whether inflammatory conditions affect prion pathogenesis. We administered prions to mice with 5 inflammatory diseases of kidney, pancreas or liver. In all cases, chronic lymphocytic inflammation enabled prion accumulation in otherwise prion-free organs. Inflammatory foci consistently correlated with lymphotoxin upregulation and ectopic induction of PrPC-expressing FDC-M1+ cells, whereas inflamed organs of mice lacking lymphotoxin-alpha or its receptor accumulate neither PrPSc nor infectivity upon prion inoculation. By expanding the tissue distribution of prions, chronic inflammatory conditions may act as modifiers of natural and iatrogenic prion transmission.******[4]Date: Thu 20 Jan 2005

 

From: Terry S. Singeltary Sr.

 

Source: Reuters News Agency, Thu 20 Jan 2005 [edited]

 


 

 

 

Study Finds that Illness May Promote Spread of Mad Cow Prion

 

 

------------------------------------------------------------

 

 

The agent that transmits mad cow disease and related diseases may spread further in the body of an animal suffering from certain illnesses, scientists said on Thu 20 Jan 2005. Their finding raises the question of whether measures aimed at curbing the spread of mad cow disease, or bovine spongiform encephalopathy (BSE), are adequate, the researchers said.Tests on mice showed that prions, the protein-like fragments that transmit BSE and related diseases [e.g. variant Creutzfeldt-Jakob disease in humans], can show up in organs they are not supposed to if the mouse has an inflammatory condition. Scientists have believed that BSE-causing prions are limited to the brain, spleen, spinal cord and lymph tissue, although some tests have suggested blood and muscle tissue may also harbor the prions. The latest study, published in the journal Science, suggests prions may also sometimes be found in the kidney, pancreas and liver. "We administered prions to mice with 5 inflammatory diseases of kidney, pancreas or liver," wrote the researchers, led by top prion expert Dr. Adriano Aguzzi of the University Hospital of Zurich in Switzerland.Aguzzi and colleagues in Britain and the United States inoculated specially bred mice with prions and checked to see if the prions spread in their bodies when the mice had an inflammatory condition. This is because other studies had suggested that prions might be attracted to immune system inflammatory cells. "In all cases, chronic lymphocytic inflammation enabled prion accumulation in otherwise prion-free organs," the researchers wrote.BSE peaked in British cattle herds in the mid-1990s, and a few cases have been reported in other countries. Canada reported its 3rd case this month. People who eat BSE-infected beef products can develop a related human brain disease called variant Creutzfeldt-Jakob disease or vCJD. There is no treatment or cure. [As of 4 Feb 2005, so far in the UK for the year 2005 there have 8 referrals of suspected CJD; and there have been 8 deaths from sporadic CJC, one from GSS and none from familial, iatrogenic or variant CJD. - Mod.CP]. It has killed 148 Britons, and 5 [now 6] Britons are alive with the disease, according to the British Department of Health's monthly report on the disease. The World Health Organization says it has reports of 6 cases in France, one in Ireland, one in Italy, one in Canada and one in the United States [and one in Japan: see; ProMED-mail post "CJD (new var.) - Japan: death 20050204.0381" - Mod.CP] Experts believed BSE first appeared when cattle were fed improperly rendered remains of sheep infected with scrapie, a related disease. In 1997, the United States and Canada imposed animal feed bans, and have mandated the removal of materials believed to carry infectious prions. These include the skull, brain, nerves attached to the brain, eyes, tonsils, spinal cord and attached nerves, plus a portion of the small intestine. The study suggests that even symptom-free animals may also have prions in their liver, kidney, and pancreas.--

 

Terry S. Singeltary Sr.flounder@wt.net

 

****** [5]Date: Fri 21 Jan 2005From: ProMED-mail promed@promedmail.org

 

Souce: New York Times, Fri 21 Jan 2005 [edited]

 


 

 

Study Finds Broader Reach for Mad Cow Proteins

 

----------------------------------------------

 

Mad cow disease has long been thought to occur in just the brains and nervous systems of infected animals. But scientists are reporting today that the proteins thought to cause the disease can travel to other organs as well. The research is based on experiments with mice, but if it is borne out in other species, it may suggest that no part of an infected animal is safe to eat. The disease leads to a fatal brain disease in humans [variant Creutzfeldt-Jakob disease].In the mouse experiments, reported in the journal Science [see [3] above], researchers in Switzerland found that prions, proteins that are the infectious agent in mad cow disease, follow immune cells, called lymphocytes, in the body. When mice were given chronic infectious diseases of the liver, kidney and pancreas and then inoculated with prions, the prions made their way to the infected organs. Dr. Adriano Aguzzi, a neuropathologist at the University Hospital in Zurich, who led the experiments, said this meant that cows and sheep infected with prions could harbor the disease in any inflamed organ.But Dr. David R. Smith, a veterinarian at the University of Nebraska, said the research did not raise alarms about American beef. For one thing, he said, livestock with obvious signs of systemic infection, like a fever, are not allowed into the food supply. And most American cattle are slaughtered while they are young and at reduced risk of infection. Many countries, including the United States, require the removal of skulls, brains, eyes, spinal cords and other nervous tissues from slaughtered animals because prions are known to accumulate in those tissues. Even in countries with mad cow disease, mainly in Europe, meat is considered safe if those tissues are removed, Dr. Aguzzi said. But the disease could spread more readily if infections are not obvious or if inspections are sloppily done, he said.[

 

Byline: Sandra Blakeslee]--ProMED-mail

 

******[6]Date: Fri 4 Feb 2005

 

From: Terry S. Singeltary Sr.

 

Source: Spongiform Encephalopathy Advisory Committee (SEAC), Position Paper, January 2005 [edited]

 


 

 

SNIP...SEE FULL TEXT ;

 

 


 

 

 

-------- Original Message --------

 

Subject: re-Mother passes on CJD to unborn baby

 

SUNDAY TELEGRAPH Sun, 17

 

Sep 2000 10:09:01 –0700

 

Date: Sun, 26 Dec 2004 11:32:26 –0600

 

From: "Terry S. Singeltary Sr."

 

Reply-To: BSE-L

 

 

Greetings list members,

 

> re-Mother passes on CJD to unborn baby SUNDAY TELEGRAPH Sun, 17 Sep

 

> 2000 10:09:01 –0700

 

 

WHY is it we have heard nothing else about this case?

 

WHAT is the latest about this child that was supposedly to have been infected with nvCJD via his mother from birth, after which the mother passed on with confirmed nvCJD ???

 

 

thank you, kind regards,

 

Terry

 

 

 

Date: Sun, 17 Sep 2000 10:09:01 –0700

 

Reply-To: BSE-L

 

Sender: BSE-L

 

From: "Terry S. Singeltary Sr."

 

 Subject: Mother passes on CJD to unborn baby SUNDAY TELEGRAPH

 

Bovine Spongiform Encephalopathy

 

ISSUE 1941 Sunday 17 September 2000

 

Mother passes on CJD to unborn baby

 

 

By Rajeev Syal, Jenny Booth and Chris Hastings Scientists shocked as disease reveals new deadly traits Tragic inheritance of baby 'born with CJD' BSE report DOCTORS believe that a baby girl has been born with new variant Creutzfeldt-Jakob disease, the human form of mad cow disease. Her mother died of the illness earlier this year. Four specialists who have examined the 11-month-old girl believe that she is exhibiting the symptoms of vCJD and that she contracted the condition in the womb. The Telegraph knows the identity of the child, but cannot name her for legal reasons. The specialists have passed on their findings to the child's grandmother after tests failed to detect any other ailment in the girl. Only a post-mortem examination, however, can offer conclusive proof of vCJD. If confirmed, this would be the first known example of vCJD being transmitted from mother to child, and will heighten fears that the disease can be transmitted through blood. One leading microbiologist believes that some of the 67 people who have already died of vCJD may have inherited it from their mothers, rather than contracting it from eating infected meat. The baby's 50-year-old grandmother, who is now her legal guardian, said the doctors suspected that prions - the infectious agents believed to cause the disease - had been passed on to the baby in the womb and had given her brain damage. She said: "They don't know if it's gone into incubation. If so, it could be years before we can finally confirm the disease." The health of the child has been the subject of speculation since her mother died of vCJD in May, seven months after giving birth. The girl was found to have brain damage and has been suffering from fits and convulsions. Doctors have said that she is growing at half the normal rate for a child of her age and suffers from poor sight and abnormally stiff limbs. Her appendix has been examined by doctors looking for signs of vCJD, but the tests proved inconclusive. She will undergo further brain scans later this year. On Friday, The Lancet reported research by scientists at the Institute for Animal Health confirming for the first time that BSE can be transmitted in sheep by infected blood transfusions. The finding increases the likelihood that a vCJD-infected mother could pass on the disease to her baby. Richard Lacey, the emeritus professor of medical microbiology at Leeds University, said that it was "inevitable" that infected mothers would pass on vCJD through the placenta. He said: "The only thing that is uncertain is the scale on which it is happening." New variant CJD, a fatal disease of the brain and nervous system, is believed to have been transmitted to humans through eating beef infected with bovine spongiform encephalopathy. The Ministry of Agriculture admitted in 1996 that a pregnant cow could pass BSE to its unborn calf. Maternal transmission also occurs in sheep, rats and mice. Scientists have observed that offspring often develop the disease more virulently than the parent and after a much shorter incubation period. Until now, researchers have been baffled at the youth of the 67 people known to have died of vCJD. Their average age is 27. Most victims were aged 18 to 40. Dr Rob Will, of the National CJD Surveillance Unit in Edinburgh, has suggested that the victims caught the disease through eating cheap mechanically recovered meat used in school meals or even baby food. Dr Lacey however suspects that some may have contracted the illness from their mothers. The Telegraph has also learnt that the Department of Health is now considering the use of disposable surgical instruments throughout the NHS because of growing concern that blood and tissue from vCJD carriers could remain infectious even after sterilisation. As this newspaper revealed four years ago, tissue from such patients is capable of passing ordinary CJD to healthy patients, yet current standards for sterilising equipment are not adequate to destroy the prions.

 

 


 

 

 

ISSUE 1941 Sunday 17 September 2000

 

Tragic inheritance of baby 'born with CJD'

 

By Rajeev Syal, Chris Hastings and Jenny Booth

 

Mother passes on CJD to unborn baby THE dark-haired baby attracts admiring glances wherever she goes. She has her mother's striking blue eyes, says her adoring grandmother. Medical experts believe, however, that she is the first child to inherit the disease which killed her mother, variant Creutzfeldt-Jakob disease, while still in the womb. The child's 50-year-old grandmother, who has to feed the 11-month-old girl through a tube, said: "Every time I look at her, I see the agony that my daughter endured in her last days. Seeing my own child die in agony nearly killed me and now I am terrified that I will also see my grandchild die in the same way." For months she suspected that her granddaughter was suffering from the symptoms of vCJD. Over recent weeks, her worst fears have been confirmed by doctors from the leading London hospital that is treating her grandchild. The tragedy began in July 1998, when the woman's 22-year-old daughter - who ran her own catering business - became moody, tired and constantly tearful. Her daughter's frequent outbursts of temper were untypical; the two normally lived harmoniously together in a semi-detatched home in a Warwickshire village. By February last year, the young woman had become pregnant. She developed severe back trouble and, five months into her pregnancy, had to give up work. She could hardly move her arms and legs and had to be helped around the house. Other symptoms included pins and needles in her legs and swollen and sore lips. Doctors were mystified as to the cause of the illness. In October, to try to protect mother and child, the baby girl was delivered by Caesarean section weighing 6lb 4oz. Immediately, however, the doctors were aware that the little girl had difficulties swallowing and she was placed in a special baby care unit. The family was told by doctors two days after the birth that the baby probably had brain damage. The specialists decided to conduct a series of tests on the child. The family had begun to guess the truth. The dead woman's mother recalled: "I had spoken to someone who told me that their relative had died of CJD, and I had seen the news reports on television about cows. Then it dawned on me; my daughter's moods and the jerky movements she had begun to suffer were similar. It was an awful moment." By January, vCJD was confirmed in the mother by a biopsy on her tonsils - a procedure that is 98 per cent accurate.After this she was warned that her baby may also have contracted the disease.The young woman was virtually confined to a wheelchair and her memory was so bad that she sometimes failed to recognise her mother and her child. The baby's father had moved away from the area. Doctors tried to discover if her baby also had vCJD, but because the case was unique, and hampered by the poor health of the child, they were not sure how to reach a diagnosis. In May, the child's mother died after months of suffering. In the same month, doctors removed the little girl's appendix and took samples of her lymph tissue in the hope that an analysis would show whether she was carrying the prions - aberrant proteins - that caused the disease that killed her mother. According to the baby's grandmother, the tests carried out by the doctors were necessarily inconclusive because vCJD infection can only be finally confirmed after death through a post-mortem. They nevertheless believe that her granddaughter has been suffering from the effects of vCJD from the time of her conception. Caring for her dead daughter's child has now become the focus of the woman's life, and it is proving to be a daunting task. Her granddaughter's eyesight has been affected, and it is impossible to know how much she can see. Her limbs are stiff and she needs physiotherapy. She sleeps a lot of the time, as her mother did when she was ill. Last week she was suffering fits and convulsions, and doctors have said that she is growing at half the normal rate. She is to undergo further examinations by vCJD specialists later this year. Her grandmother said: "The appalling thing is that I am watching my granddaughter die while the Government fails to warn others that they may be passing the disease on. I want this baby's case highlighted because no other family should go through what we have been through,"

 

 


 

 

ISSUE 1941 Sunday 17 September 2000

 

Scientists shocked as disease reveals new deadly traits

 

By Robert Matthews

 

THE growing concern over the health of the baby born to a mother with variant CJD and the new evidence, announced last week, that the disease may have spread through blood transfusions, highlight the disturbing ability of vCJD to surprise the experts. A conclusive diagnosis of vCJD in the 11-month-old child would imply a far shorter incubation period than many scientists thought possible. It would also mean that the disease can be passed down the generations, not merely acquired through contact with infected tissue. Scientists have yet to pin down the likely size of the vCJD epidemic, with estimates for Britain ranging from about 100 cases to more than 100,000; so far there have been only 82 probable or confirmed cases. The case of the baby girl means that scientists are now admitting that many predictions may have to be rethought. According to Dr Neil Ferguson of the University of Oxford, a leading expert on the mathematics of epidemics, so-called vertical transmission down the generations has, at least until now, been thought to be relatively unimportant. Dr Ferguson said: "It very much depends on the probability of it taking place. If a woman has to be very sick and symptomatic in order to give it to her baby, then the number of cases it creates are going to be very small, because she is unlikely to get pregnant." The mother of the baby at the centre of the current concern is, however, understood to have been showing only minor symptoms of the disease at the time of conception; only later in her pregnancy did she develop the classic symptoms of vCJD from which she died in May this year. Richard Lacey, an emeritus professor of medical microbiology at Leeds University, said that the Telegraph story had wider implications than its obvious medical significance. Prof Lacey said: "The only thing that is certain is the scale on which it is happening. That will take decades to find out. I am aware of other cases where maternal transmission could be an issue; this isn't the only one. "This poses difficult ethical problems: to what extent should individuals be told of the risk? Should such a person be told not to give blood when he or she is old enough to do so? What effect will this knowledge have on that person's way of life, on their emotions? There needs to be some sort of discussion about how we cope with it, but at the moment there is nothing." Epidemiologists are puzzled by the fact that vCJD is predominantly affecting young people, while classic CJD is a disease of the old. Prof Lacey suggested that one possible explanation is that the teenagers and young people who have died from vCJD may have contracted the disease from their mothers while in the womb. He added that it is a recognised clinical syndrome that infectivity accumulates when it is passed on from one generation to the next. Dr Stephen Dealler, an expert on BSE and vCJD at Burnley Hospital, said that it had been believed that mother-to-offspring infection could take place in cows, but only with a considerable incubation period. "The thinking is that it may take place in cows, but the incubation period is still three to five years," he said. "This would lead us to expect an incubation period of around seven years in humans. If the baby does have vCJD, that's a very fast incubation period." Last week's revelation resulting from animal experiments that the disease may be transferred through blood transfusions from infected people with no symptoms was being played down by government scientists, who said that all British blood is screened to remove cells that may harbour vCJD. The Telegraph has learnt, however, that the Department of Health is seriously considering the use of disposable surgical instruments throughout the National Health Service. This follows growing concern that blood and tissue from asymptomatic carriers of the disease could remain infectious even after sterilisations.

 

 


 

 

TSS

 

 

Terry S. Singeltary Sr. P.O. Box 42 Bacliff, Texas USA 77518

 

 

============================================

 

 

Subject: mother-to-child CJD (more downplaying or just hope?)

 

Date: Thu, 21 Sep 2000 20:56:41 –0700

 

From: "Terry S. Singeltary Sr."

 

Reply-To: Bovine Spongiform Encephalopathy

 

To: BSE-L@uni-karlsruhe.de

 

######### Bovine Spongiform Encephalopathy #########

 

The first case of mother-to-child transmission of vCJD?

 

 

Lancet 2000; 356: 1085 - 1092 Download PDF (109 Kb)

 

 

Last week UK newspapers reported that four UK doctors had revealed that they suspected an 11-month-old girl had variant Creutzfeldt-Jakob disease (vCJD), which she may have contracted from her mother, who died from the disease in May.

 

 

The child has brain damage, is unable to swallow, and has convulsions and stiff limbs. Doctors have not been able to give another explanation for her signs and tests for the abnormal prion protein in appendix and lymph tissue have been inconclusive. Proof of vCJD in adults requires examination of brain tissue at necropsy or by brain biopsy.

 

 

Prof James Ironside, a neuropathologist from the National Creutzfeldt-Jakob Disease Surveillance Unit, Edinburgh, UK, says "the position we are in just now is suspicion, as far as I am aware, and it is not proven that this child has the disease". In occasional cases of iatrogenic CJD occurring in younger patients during pregnancy there has been no evidence of maternal transmission, adds Ironside.

 

 

Chris Verity, a paediatric neurologist from Addenbrooke's Hospital, Cambridge, UK, who is part of a national paediatric vCJD surveillance team, stresses the need for caution before drawing conclusions from this case. "We cannot comment on individual cases . . . and there are a whole lot of reasons why children may have problems with development".

 

 

Haroon Ashraf

 

 


 

 

so, what about sutures ???

 

Other US BSE risks: the imported products picture 24 Jul 00 Trade Statistics: UK to US Compiled by Terry S. Singeltary Sr of Bacliff, Texas

 

[Opinion (webmaster): The US has focused for years on tracing, containing, and eradicating live animal imports from the UK or other countries with acknowledged BSE like Belgium, including some 499 cattle and the Vermont sheep. This strategy does not acknowledge imports of rendered bovine products from England during the BSE period nor secondary products such as surgical catgut, which is to say surgical cowgut, or dairy cattle embryos, vaccines for veterinarian and human medicines. What has become of these?

 

Mr. Singeltary, who lost his mother to CJD of unexplained origin a few years back and went on to became a well-known TSE activist, has tracked down voluminous pertinent import data through correspondence with UK officials and searches of government web sites. Imports of such products are frequently cited by Europeans in rating BSE risks in the US and in shutting out US exports.

 

Many people's eyes glaze over when reviewing reams of sometimes older trade statistics. There is no proof that any of the imported products was contaminated with BSE nor if so, any evidence that any BSE product lead to infection in US livestock, surgical patients, or what not. Nonetheless, the data obtained by Mr. Singeltary establish that an appalling variety and tonnage of products that were imported by the US from the UK and othr BSE-affected countries during the peak of the BSE epidemic years.

 

10 January 1990 COMMERCIAL IN CONFIDENCE

 

NOT FOR PUBLICATION

 

COMMITTEE ON SAFETY OF MEDICINES WORKING PARTY ON BOVINE SPONGIFORM ENCEPHALOPATHY

 

SURGICAL CATGUT SUTURES 2.1 At the first meeting of the Working Party on Bovine Spongiform Encephalopathy on 6 September 1989, detailed consideration was given to XXXXX Surgical Catgut. This arose from the Company's response to the Letter to Licence Holders, indicating that the bovine small intestine source material was derived from UK cattle, unlike 8 other licenced catgut sutures. In contrast XXXXX Surgical Catgut was stated to hold over 90% share of the market for catgut sutures, and to constitute approximately 83% of all sutures used in U.K. IMPORTS OF SUTURES FROM THE KNOWN BSE COUNTRY;

 

 


 

 

 

see full text ;

 

 


 

 

 

Tuesday, February 8, 2011

 

U.S.A. 50 STATE BSE MAD COW CONFERENCE CALL Jan. 9, 2001

 


 

 

 

Friday, December 23, 2011

 

Detection of PrPres in Genetically Susceptible Fetuses from Sheep with Natural Scrapie

 


 

 

 

 

 

Sunday, September 1, 2013

 

 

Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy

 

 

We previously described the biochemical similarities between PrPres derived from L-BSE infected macaque and cortical MM2 sporadic CJD: those observations suggest a link between these two uncommon prion phenotypes in a primate model (it is to note that such a link has not been observed in other models less relevant from the human situation as hamsters or transgenic mice overexpressing ovine PrP [28]). We speculate that a group of related animal prion strains (L-BSE, c-BSE and TME) would have a zoonotic potential and lead to prion diseases in humans with a type 2 PrPres molecular signature (and more specifically type 2B for vCJD)

 

snip...

 

Together with previous experiments performed in ovinized and bovinized transgenic mice and hamsters [8,9] indicating similarities between TME and L-BSE, the data support the hypothesis that L-BSE could be the origin of the TME outbreaks in North America and Europe during the mid-1900s.

 

 


 

 

 

 

 

Monday, September 02, 2013

 

Atypical BSE: role of the E211K prion polymorphism

 

Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

 

Location: Virus and Prion Research Unit

 


 

 

 

 

 

Saturday, July 6, 2013

 

Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy

 

Research Article

 


 

 

 

 

Sunday, August 11, 2013

 

Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013

 

Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010

 


 

 

 

Friday, August 16, 2013

 

Creutzfeldt-Jakob disease (CJD) biannual update August 2013 U.K. and Contaminated blood products induce a highly atypical prion disease devoid of PrPres in primates

 


 

 

 

 

Sunday, March 31, 2013

 

Creutzfeldt Jakob Disease CJD worlds youngest documented victim, 11 years old, shall we pray

 


 

 

 

Monday, January 14, 2013

 

Gambetti et al USA Prion Unit change another highly suspect USA mad cow victim to another fake name i.e. sporadic FFI at age 16 CJD Foundation goes along with this BSe

 


 

 

 

Monday, December 31, 2012

 

Creutzfeldt Jakob Disease and Human TSE Prion Disease in Washington State, 2006–2011-2012

 


 

 

 

Saturday, December 29, 2012

 

MAD COW USA HUMAN TSE PRION DISEASE DECEMBER 29 2012 CJD CASE LAB REPORT

 


 

 

 

MAD COW USDA ATYPICAL L-TYPE BASE BSE, the rest of the story...

 


 

 

 

Tuesday, November 6, 2012

 

Transmission of New Bovine Prion to Mice, Atypical Scrapie, BSE, and Sporadic CJD, November-December 2012 update

 


 

 

 

Tuesday, June 26, 2012

 

Creutzfeldt Jakob Disease Human TSE report update North America, Canada, Mexico, and USDA PRION UNIT as of May 18, 2012

 

type determination pending Creutzfeldt Jakob Disease (tdpCJD), is on the rise in Canada and the USA

 


 

 

 

Saturday, March 5, 2011

 

MAD COW ATYPICAL CJD PRION TSE CASES WITH CLASSIFICATIONS PENDING ON THE RISE IN NORTH AMERICA

 


 

 

 

Sunday, February 12, 2012

 

National Prion Disease Pathology Surveillance Center Cases Examined1 (August 19, 2011) including Texas

 


 

 

 

Monday, August 9, 2010

 

Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein or just more Prionbaloney ?

 


 

 

 

Wednesday, March 28, 2012

 

VARIABLY PROTEASE-SENSITVE PRIONOPATHY IS TRANSMISSIBLE ...price of prion poker goes up again $

 

OR-10 15:25 - 15:40 VARIABLY PROTEASE-SENSITIVE PRIONOPATHY IS TRANSMISSIBLE IN BANK VOLES Nonno

 


 

 

 

Sunday, August 09, 2009

 

CJD...Straight talk with...James Ironside...and...Terry Singeltary... 2009

 


 

 

 

Tuesday, August 18, 2009

 

BSE-The Untold Story - joe gibbs and singeltary 1999 – 2009

 


 

 

 

Monday, October 10, 2011

 

EFSA Journal 2011 The European Response to BSE: A Success Story

 

snip...

 

EFSA and the European Centre for Disease Prevention and Control (ECDC) recently delivered a scientific opinion on any possible epidemiological or molecular association between TSEs in animals and humans (EFSA Panel on Biological Hazards (BIOHAZ) and ECDC, 2011). This opinion confirmed Classical BSE prions as the only TSE agents demonstrated to be zoonotic so far but the possibility that a small proportion of human cases so far classified as "sporadic" CJD are of zoonotic origin could ***not be excluded. Moreover, transmission experiments to non-human primates suggest that some TSE agents in addition to Classical BSE prions in cattle (namely L-type Atypical BSE, Classical BSE in sheep, transmissible mink encephalopathy (TME) and chronic wasting disease (CWD) agents) might have zoonotic potential.

 

snip...

 

 


 

 


 

 

 

see follow-up here about North America BSE Mad Cow TSE prion risk factors, and the ever emerging strains of Transmissible Spongiform Encephalopathy in many species here in the USA, including humans ;

 


 

 

 

Thursday, August 12, 2010

 

Seven main threats for the future linked to prions

 

First threat

 

The TSE road map defining the evolution of European policy for protection against prion diseases is based on a certain numbers of hypotheses some of which may turn out to be erroneous. In particular, a form of BSE (called atypical Bovine Spongiform Encephalopathy), recently identified by systematic testing in aged cattle without clinical signs, may be the origin of classical BSE and thus potentially constitute a reservoir, which may be impossible to eradicate if a sporadic origin is confirmed.

 

***Also, a link is suspected between atypical BSE and some apparently sporadic cases of Creutzfeldt-Jakob disease in humans. These atypical BSE cases constitute an unforeseen first threat that could sharply modify the European approach to prion diseases.

 

Second threat

 

 

snip...

 

 


 

 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 


 

 

 

TSS

Monday, September 2, 2013

PRION2013 AD.22: Bovine spongiform encephalopathy, chronic wasting disease and scrapie (TSE surveillance) programs in Alberta, Canada

AD.22: Bovine spongiform encephalopathy, chronic wasting disease and scrapie (TSE surveillance) programs in Alberta, Canada
 
Hernan Ortegon,1 Eva Chow,1 Christa Coetser,3 Gerald Hauer,1 Margo Pybus2 and Ana M. Ulmer-Franco1
 
1Alberta Agriculture and Rural Development; Edmonton, AS Canada; 2Alberta Environment and Sustainable Resource Development; Edmonton, AB Canada; 3Canadian Food Inspection Agency; Calgary, AB Canada
 
Bovine spongiform encephalopathy (BSE) in cattle, Chronic Wasting Disease (CWD) in cervids, and scrapie in sheep and goats are reportable diseases under both the provincial Animal Health Act (Alberta) and the federal Health of Animals Act (Canada). Alberta Agriculture and Rural Developmemt (ARD), in collaboration with Environment and Sustainable Resource Development, the Canadian Food Inspection Agency and the livestock industry, have performed over the past 8 y enhanced surveillance for these diseases. An overview of the history, characteristics, development and evolution of these programs will be presented.
 
An integrated approach between both levels of government and provincial specialists led to the delivery of three high-quality surveillance programs in Alberta (AB): The Canada and Alberta BSE Surveillance Program (CABSESP) was initiated on July 1, 2004 to meet international requirements on BSE surveillance, to determine the prevalence of BSE and the influence of several mitigation strategies. These actions increased consumer confidence and market access for Canadian cattle and meat products. Today, Canada exports beef to more than 50 countries. The CABSESP has tested approximately 145,000 animals for BSE since 2003. Out of the 18 BSE Canadian cases, 13 were detected by the CABSESP in AB.
 
The mandatory CWD surveillance program (MCWDSP) for farmed cervids was established in AB in 2002. Under this program cervid producers are required to submit samples from all farmed cervids one year of age and older dying on farm, culled or slaughtered. The MCWDSP has opened international markets in the US, Europe, Middle East and Eastern Asia to AB farmed cervids by providing confidence to consumers on the herd's freedom from CWD. To date, only three cases of CWD in farmed cervids were detected in AB, all in 2002, which was followed by full eradication of those herds. In addition, the TSE laboratory of ARD has tested over 50,000 samples from wild cervids finding 155 cases to date in 137 mule deer, 17 white-tailed deer, and one moose.
 
Scrapie surveillance in sheep and goats has been accomplished by three programs: the AB Abattoir surveillance, which targets abattoir populations; the AB on-farm scrapie program, which targets non-registered on-farms deaths; and the National voluntary scrapie flock certification program, which targets certified flocks. TSE surveillance in AB responded to multiple challenges resulting from evolving markets, national and international animal health requirements and new scientific discoveries, evolving and adapting to new conditions thanks to the joint effort of all parties involved.
 
 
 
 
 
 
The disease was confirmed only in elk in the Republic of Korea in 2001, 2004 and 2005. Epidemiological investigations showed that CWD was introduced via importation of infected elk from Canada between 1994 and 1997.
 
 
 
 
Friday, May 13, 2011
 
Chronic Wasting Disease (CWD) outbreaks and surveillance program in the Republic of Korea Chronic Wasting Disease (CWD) outbreaks and surveillance program in the Republic of Korea
 
On 28 December 2000, information from the Canadian government showed that a total of 95 elk had been exported from farms with CWD to Korea. These consisted of 23 elk in 1994 originating from the so-called “source farm” in Canada, and 72 elk in 1997, which had been held in pre export quarantine at the “source farm”.Based on export information of CWD suspected elk from Canada to Korea, CWD surveillance program was initiated by the Ministry of Agriculture and Forestry (MAF) in 2001. All elks imported in 1997 were traced back, however elks imported in 1994 were impossible to identify. CWD control measures included stamping out of all animals in the affected farm, and thorough cleaning and disinfection of the premises.
 
In addition, nationwide clinical surveillance of Korean native cervids, and improved measures to ensure reporting of CWD suspect cases were implemented. Total of 9 elks were found to be affected. CWD was designated as a notifiable disease under the Act for Prevention of Livestock Epidemics in 2002.
 
Additional CWD cases - 12 elks and 2 elks - were diagnosed in 2004 and 2005.
 
Since February of 2005, when slaughtered elks were found to be positive, all slaughtered cervid for human consumption at abattoirs were designated as target of the CWD surveillance program.
 
Currently, CWD laboratory testing is only conducted by National Reference Laboratory on CWD, which is the Foreign Animal Disease Division (FADD) of National Veterinary Research and Quarantine Service (NVRQS).
 
In July 2010, one out of 3 elks from Farm 1 which were slaughtered for the human consumption was confirmed as positive.
 
Consequently, all cervid – 54 elks, 41 Sika deer and 5 Albino deer – were culled and one elk was found to be positive.
 
Epidemiological investigations were conducted by Veterinary Epidemiology Division (VED) of NVRQS in collaboration with provincial veterinary services.
 
Epidemiologically related farms were found as 3 farms and all cervid at these farms were culled and subjected to CWD diagnosis.
 
Three elks and 5 crossbreeds (Red deer and Sika deer) were confirmed as positive at farm 2. All cervids at Farm 3 and Farm 4 – 15 elks and 47 elks – were culled and confirmed as negative.
 
Further epidemiological investigations showed that these CWD outbreaks were linked to the importation of elks from Canada in 1994 based on circumstantial evidences.
 
In December 2010, one elk was confirmed as positive at Farm 5. Consequently, all cervid – 3 elks, 11 Manchurian Sika deer and 20 Sika deer – were culled and one Manchurian Sika deer and seven Sika deer were found to be positive.
 
This is the first report of CWD in these sub-species of deer. Epidemiological investigations found that the owner of the Farm 2 in CWD outbreaks in July 2010 had co-owned the Farm 5. In addition, it was newly revealed that one positive elk was introduced from Farm 6 of Jinju-si Gyeongsang Namdo. All cervid – 19 elks, 15 crossbreed (species unknown) and 64 Sika deer – of Farm 6 were culled, but all confirmed as negative.
 
: Corresponding author: Dr. Hyun-Joo Sohn (+82-31-467-1867, E-mail: shonhj@korea.kr)
 
2011 Pre-congress Workshop: TSEs in animals and their environment 5
 
 
 
 
 
 
 
 
 
Additional Cases of Chronic Wasting Disease in Imported Deer in Korea
 
*Tae-Yung KIM1) 3), *Hyun-Joo SHON2), *Yi-Seok JOO2), *Un-Kyong MUN2), *Kyung-Sun KANG3), *Yong-Soon LEE3)
 
1) Animal Health Division, Ministry of Agriculture & Forestry 2) National Veterinary Research & Quarantine Service 3) Department of Veterinary Public Health, College of Veterinary Medicine, Seoul National University
 
Released 2005/09/05 received 2005/01/21 accepted 2005/05/27 Keywords: Chronic Wasting Disease (CWD), horizontal transmission
 
Chronic Wasting Disease (CWD), which had previously occurred only in the U.S.A. and Canada, broke out in a farm at Chungbuk, Korea from imported Canadian deer (Aug. 8, 2001). CWD distribution, through surveillance and epidemiologic investigations, was reported for 93 deer (43 from the CWD originating farm and 50 imported with the CWD originating farm's deer) out of 144 deer (72 from the CWD originating farm and 72 imported with the CWD originating farm's deer) that were breeding at 30 different farms. On Oct. 4 and Oct. 8, 2001, additional cases of CWD were investigated. As a result of slaughtering cohabitating deer, it was verified that other imported deer from Canada were also infected with CWD. Since it was thought that this might cause horizontal transmission, 93 deer imported from Canada in 1997 and 130 cohabitating Korean deer were slaughtered and examined. There were no infected Korean deer, but CWD re-occurred on Nov. 20, 2004 and is still under investigation.
 
 
 
 
 
 
 
Wednesday, August 11, 2010
 
REPORT ON THE INVESTIGATION OF THE SIXTEENTH CASE OF BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN CANADA
 
 
 
 
Thursday, August 19, 2010
 
REPORT ON THE INVESTIGATION OF THE SEVENTEENTH CASE OF BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN CANADA
 
 
 
 
Friday, March 4, 2011
 
Alberta dairy cow found with mad cow disease
 
 
 
 
Tuesday, May 21, 2013
 
*** Canada, USA, Bad feed, mad cows: Why we know three BSE cases had a common origin and why the SSS policy is in full force $$$
 
 
 
 
CFIA, USDA, AND OIE SHOOT, SHOVEL, AND SHUT THE HELL UP SSS BSE TSE PRION MAD COW TYPE POLICY $$$, and the media is buying it hook, line, and sinker $$$
 
 
 
EDMONTON - Some of former Alberta premier Ralph Klein's most colourful quotes — and the reactions they elicited:
 
 
SNIP...
 
 
"This all came about through the discovery of a single, isolated case of mad cow disease in one Alberta cow on May 20th.
 
 
The farmer — I think he was a Louisiana fish farmer who knew nothing about cattle ranching.
 
 
*** I guess any self-respecting rancher would have shot, shovelled and shut up, but he didn't do that." — Klein recalls how the mad cow crisis started and rancher Marwyn Peaster's role.
 
 
The premier was speaking at the Western Governors Association meeting in Big Sky, Mont. September 2004.
 
 
 
 
 
Wednesday, December 22, 2010.
 
Manitoba veterinarian has been fined $10,000 for falsifying certification documents for U.S. bound cattle and what about mad cow disease?
 
 
 
 
CENSORSHIP IS A TERRIBLE THING $$$.
 
 
Canada has had a COVER-UP policy of mad cow disease since about the 17th case OR 18th case of mad cow disease. AFTER THAT, all FOIA request were ignored $$$.
 
THIS proves there is indeed an epidemic of mad cow disease in North America, and it has been covered up for years and years, if not for decades, and it’s getting worse $$$.
 
 
 
Thursday, February 10, 2011.
 
TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY REPORT UPDATE CANADA FEBRUARY 2011 and how to hide mad cow disease in Canada Current as of: 2011-01-31.
 
 
 
 
Thursday, January 17, 2013.
 
Canada, U.S. agree on animal-disease measures to protect trade, while reducing human and animal health protection.
 
 
 
 
Reasons for the New Regulation Order No. 23 (as well as amending Order No. 149) of the State Committee for Veterinary Medicine name BSE as the reason for new import requirement. The legal title for Order No. 23 is "On Urgent Measures Aimed at Prevention and Elimination of BSE and Other Prion Infections in Cattle”. Neither Order explains how the threat of introduction of BSE can be addressed through the inspection of producers of all products of animal origin including fish, dairy products, poultry and pork. It is not clear what other concerns are addressed through the proposed inspections. Formal Notification of Trading Partners On August 3rd, Ukraine's Notification and Enquiry Point issued a legal Notification G/SPS/N/UKR/3/Rev.1 found on the Official WTO Website (Committee on Sanitary and Phytosanitary Measures)
 
 
 
 
Increased Atypical Scrapie Detections.
 
Press reports indicate that increased surveillance is catching what otherwise would have been unreported findings of atypical scrapie in sheep. In 2009, five new cases have been reported in Quebec, Ontario, Alberta, and Saskatchewan. With the exception of Quebec, all cases have been diagnosed as being the atypical form found in older animals. Canada encourages producers to join its voluntary surveillance program in order to gain scrapie-free status. The World Animal Health will not classify Canada as scrapie-free until no new cases are reported for seven years. The Canadian Sheep Federation is calling on the government to fund a wider surveillance program in order to establish the level of prevalence prior to setting an eradication date. Besides long-term testing, industry is calling for a compensation program for farmers who report unusual deaths in their flocks.
 
 
 
 
Thursday, February 23, 2012
 
Atypical Scrapie NOR-98 confirmed Alberta Canada sheep January 2012
 
 
 
 
Wednesday, April 4, 2012
 
20120402 - Breach of quarantine/Violation de la mise en quarantaine of an ongoing Scrapie investigation
 
 
 
 
Sunday, September 1, 2013
 
Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy
 
We previously described the biochemical similarities between PrPres derived from L-BSE infected macaque and cortical MM2 sporadic CJD: those observations suggest a link between these two uncommon prion phenotypes in a primate model (it is to note that such a link has not been observed in other models less relevant from the human situation as hamsters or transgenic mice overexpressing ovine PrP [28]). We speculate that a group of related animal prion strains (L-BSE, c-BSE and TME) would have a zoonotic potential and lead to prion diseases in humans with a type 2 PrPres molecular signature (and more specifically type 2B for vCJD)
 
snip...
 
Together with previous experiments performed in ovinized and bovinized transgenic mice and hamsters [8,9] indicating similarities between TME and L-BSE, the data support the hypothesis that L-BSE could be the origin of the TME outbreaks in North America and Europe during the mid-1900s.
 
 
 
 
Monday, September 02, 2013
 
Atypical BSE: role of the E211K prion polymorphism
 
Research Project: TRANSMISSION, DIFFERENTIATION, AND PATHOBIOLOGY OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES
 
Location: Virus and Prion Research Unit
 
 
 
 
Sunday, July 21, 2013
 
Welsh Government and Food Standards Agency Wales Joint Public Consultation on the Proposed Transmissible Spongiform Encephalopathies (Wales) Regulations 2013 Singeltary Submission WG18417
 
 
 
 
Tuesday, July 2, 2013
 
APHIS USDA Administrator Message to Stakeholders: Agency Vision and Goals Eliminating ALL remaining BSE barriers to export market
 
 
 
 
Tuesday, May 21, 2013
 
Canada, USA, Bad feed, mad cows: Why we know three BSE cases had a common origin and why the SSS policy is in full force $$$
 
 
 
 
Greetings,
 
CJD surveillance in the Canada and the USA has been in place well long enough, for this same excuse (improved P/T reporting) year after year of reporting increases to be a valid excuse anymore, in my opinion.
 
I don’t buy this same old song and dance anymore.
 
it’s the same recording we hear year after year, decade after decade, happenstance of bad luck, increase is due to better surveillance, yada, yada, yada $$$
 
North America is awash in animal Transmissible Spongiform Encephalopathy TSE prion disease in many, many species. All of which are consumed/exposed in many different ways, by humans and animals.
 
This excuse ‘’improved P/T reporting’’ is old, and it is what it is, an excuse, to protect the industries that are involved. nothing has changed in almost 3 decades, except the people. it’s the same old BSe.
 
I will report on disturbing iatrogenic risk factors, cjd in the UK, and more data on the TSE prion disease in different species, and more from prion2013 as I can get it put together.
 
I want to thank Prion2013, and all the scientist and doctors and such that are working so hard to solve the many riddles of the TSE prion disease. ...TSS
 
 
 
Sunday, August 11, 2013
 
Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013
 
Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010
 
 
 
 
Saturday, June 15, 2013
 
Canada Fraser Health Statement on Creutzfeldt-Jakob Disease outbreak
 
 
 
 
Tuesday, May 28, 2013
 
Late-in-life surgery associated with Creutzfeldt-Jakob disease: a methodological outline for evidence-based guidance
 
 
 
 
Friday, August 16, 2013
 
Creutzfeldt-Jakob disease (CJD) biannual update August 2013 U.K. and Contaminated blood products induce a highly atypical prion disease devoid of PrPres in primates
 
 
 
 
TSS

Sunday, September 1, 2013

Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy

Evaluation of the Zoonotic Potential of Transmissible Mink Encephalopathy

 

Emmanuel E. Comoy 1,*, Jacqueline Mikol 1, Marie-Madeleine Ruchoux 1, Valérie Durand 1, Sophie Luccantoni-Freire 1, Capucine Dehen 1, Evelyne Correia 1, Cristina Casalone 2, Juergen A. Richt 3, Justin J. Greenlee 4, Juan Maria Torres 5, Paul Brown 1 and Jean-Philippe Deslys 1

 

1 CEA, Institute of Emerging Diseases and Innovative Therapies (iMETI), Division of Prions and Related Diseases (SEPIA), Route du Panorama, BP6, 92265 Fontenay-aux-Roses, France; E-Mails: jacqueline.mikol@wanadoo.fr (J.M.); mruchoux@yahoo.fr (M.-M.R.); valerie.durand@cea.fr (V.D.); sophie.luccantoni@cea.fr (S.L.); capucine.dehen@cea.fr (C.D.); evelyne.correia@cea.fr (E.C.); paulwbrown@comcast.net (P.B.); jpdeslys@cea.fr (J-P.D.)

 

2 Istituto Zooprofilattico Sperimentale del Piemonte, Via Bologna 148, 10154 Torino, Italy; E-Mail: cristina.casalone@izsto.it (C.C.)

 

3 Kansas State University, College of Veterinary Medicine, K224B Mosier Hall, Manhattan, Kansas 66506-5601 USA; E-Mail: jricht@vet.k-state.edu

 

4 National Animal Disease Center, USDA, Agricultural Research Service, 1920 Dayton Ave, Ames, Iowa 50010 USA; E-Mail: justin.greenlee@ars.usda.gov (J.J.G.)

 

5 Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria, Madrid, Spain; E-mail: jmtorres@inia.es

 

* Author to whom correspondence should be addressed; E-Mail: emmanuel.comoy@cea.fr (E.E.C.); Tel.: +33-46-54-90-05; Fax: +33-46-54-93-19. Received: 27 June 2013; in revised form: 28 July 2013 / Accepted: 30 July 2013 / Published: 30 July 2013

 

Abstract: Successful transmission of Transmissible Mink Encephalopathy (TME) to cattle supports the bovine hypothesis for the still controversial origin of TME outbreaks. Human and primate susceptibility to classical Bovine Spongiform Encephalopathy (c-BSE) and the transmissibility of L-type BSE to macaques indicate a low cattle-to-primate species barrier. We therefore evaluated the zoonotic potential of cattle-adapted TME. In less than two years, this strain induced in cynomolgus macaques a neurological disease similar to L-BSE but distinct from c-BSE. TME derived from another donor species (raccoon) induced a similar disease with even shorter incubation periods. L-BSE and cattle-adapted TME were also transmissible to transgenic mice expressing human prion protein (PrP). Secondary transmissions to transgenic mice expressing bovine PrP maintained the features of the three tested bovine strains (cattle TME, c-BSE and L-BSE) regardless of intermediate host. Thus, TME is the third animal prion strain transmissible to both macaques and humanized transgenic mice, suggesting zoonotic potentials that should be considered in the risk analysis of animal prion diseases for human health. Moreover, the similarities between TME and L-BSE are highly suggestive of a link between these strains, and therefore the possible presence of L-BSE for many decades prior to its identification in USA and Europe.

 

Keywords: primate; prion; transgenic mice; TME; cattle; raccoon; zoonotic potential

 

1. Introduction

 

Transmissible Mink Encephalopathy (TME) is a rare prion disease affecting ranch-reared mink that was reported in four isolated outbreaks in the USA in 1947, 1961, 1963 and 1985 [1], and in several other outbreaks in Canada, East Germany, Finland and the former USSR during the same time period, with prevalence rates as high as 100% and an estimated incubation period of 6 months [2]. Epidemiological studies suggested that each outbreak was due to dietary infection. Several experimental exposures of mink to ruminant prions were performed to identify the exact origin of TME. Low efficiency and rate of transmission were observed after inoculation of mink with sheep scrapie [3] and elk-derived Chronic Wasting Disease (CWD) [4] isolates with an incubation time of 2–3 years, while a 100% success rate of transmission was obtained within 12 months post-exposure to classical Bovine Spongiform Encephalopathy (c-BSE) [5]. However, in all cases, the resulting diseases differed from TME. Conversely, TME was experimentally transmitted to cattle [6,7] inducing a prion disease distinct from c-BSE within 16 to 28 months. Experimental transmissions to conventional and transgenic rodent models suggested similarities between TME and L-BSE [8,9], an atypical cattle prion strain that was incidentally identified several years ago in aged cattle through systematic testing within the framework of the European BSE epizootic [10]. It was speculated that sporadic atypical cattle BSE (H- and/or L- type) might be at the origin of c-BSE [11,12]. These observations support the hypothesis of a bovine origin to TME.

 

Currently, classical BSE is the only animal transmissible spongiform encephalopathy (TSE) considered as a zoonotic disease, since it induces a variant of Creutzfeldt-Jakob disease (CJD) in humans [13–15]. We, and others, demonstrated that the cynomolgus macaque, previously used to demonstrate the transmissibility of human prion diseases [16], constitutes a relevant experimental model to assess the BSE risk for humans [14,17–20]. The same species was also susceptible to L-BSE [21,22], developing a disease distinct from c-BSE. Taken together, these results suggested a low cattle-to-primate species barrier and raised questions about the zoonotic potential of different bovine prion strains. We chose to assess the risk for human health linked to TME-related prion strains by evaluating the transmissibility of cattle-adapted TME in this cynomolgus macaque model, in comparison to raccoon TME as a non-ruminant source of the same prion strain. In parallel, we used transgenic mice overexpressing human or bovine prion protein (PrP) to assess the relevance of our results for human situation.

 

 2. Results and Discussion

 

2.1. Transmission of Cattle-Adapted TME in Experimental Models

 

A primate intracerebrally inoculated with the equivalent of 40 mg of a TME-infected cattle brain (second passage) developed the first neurological signs of disease after less than twenty months of incubation (Table 1). It first showed slowness and weak tremors amplifying with time. Clinical signs then evolved with ataxia, hypermetria, poor vision, and apparent cognitive impairment. Appetite remained normal during the entire 3.5 months clinical period (limited weight loss) and no behavioral changes were noticed (total survival period 23 months). The presence of cerebral spongiosis and protease-resistant prion protein (PrPres) deposition (detailed hereafter) confirmed the presence of prion disease. When another, non-ruminant, source of TME was injected, disease occurred with a similar period of survival (Table 1).

 

Table 1. Survival (incubation and clinical duration) in months of individual cynomolgus macaques exposed to different prion strains.

 

In parallel, several but not all the transgenic mice overexpressing human (Met/Met) PrP (tg650 mice) intracerebrally inoculated with cattle-adapted TME inoculum exhibited cerebral PrPres: partial transmission (75 %) occurred in humanized mice that died after about 18 months of incubation (Figure 1).

 

2.2. Transmission of other cattle prion strains

 

From these results, cattle-adapted TME represents the third cattle prion strain (together with c-BSE and L-BSE) experimentally demonstrated to be transmissible to non-human primates. We confirmed in this study the previously described transmissibility of both L-BSE and c-BSE in both experimental primates [14,21] and transgenic [23,24] models.

 

In the primate model, exposure to L-BSE-infected cattle brain induced a clinical picture with incubation time and duration of illness that are similar to those observed after exposure to cattle-adapted TME, even after exposure to as little as 2.5 mg of brain tissue (Table 1). Conversely, c-BSE infected primates developed a different clinical picture, as previously described [14,21], with longer incubation periods even when they were exposed to 100 mg of brain tissue.

 

A comparison of incubation periods confirmed and magnified the higher virulence of L-BSE for macaque compared to c-BSE, which we had previously observed [21]. Moreover, since incubation periods classically increase with the dilution of initial infectious amount in experimental prion diseases, the similarity of incubation durations for primates exposed to either 25 or 2.5 mg of L-BSE-infected brain is in favor of a substantial amount of infectivity in the brains of cattle infected with the L-BSE prion strain.

 

Figure 1. Transmission studies of bovine prion strains to transgenic mice overexpressing human (tg650) or bovine (tg110) PrP. Tg650 mice (colored in blue) were intracerebrally inoculated with 20 μl of 10 % brain homogenate from cattle infected with adapted TME, L-BSE or c-BSE strains. Tg110 mice (colored in red) were inoculated directly with the same cattle inocula, or with brains from macaques or tg650 mice previously exposed to those cattle inocula. vCJD inoculum was injected as controls. Transmission results are expressed as rates of transmission (%), number of recipient mice (in brackets), and mean ± standard deviation of their incubation periods.

 

In the model of transgenic mice overexpressing human (Met/Met) PrP (tg650 mice), an incomplete transmission rate of 25% of L-BSE was observed after an incubation period of similar duration (18 months) to those from cattle TME-exposed animals, while a 100% transmission rate was observed with c-BSE, but with longer incubations (animals were euthanized 27 months post inoculation, corresponding to the lifespan of these animals in our facilities). These observations are consistent with the results obtained with L-BSE strain by Beringue et al., in this transgenic model [24] and by Kong in another humanized mouse model [25], suggesting a less efficient transmission of L-BSE and TME than c-BSE in this transgenic model, but with a shorter evolution when it occurs.

 

The overexpression of PrP in transgenic mice is often criticized as an element helping to force the way through the species barrier and extrapolation of our results in this model to the human situation should be taken with caution, since transgenic mice expressing physiological levels of human PrP are resistant to L-BSE [26]. Nevertheless, it must be noted that these ‘physiologic’ mice are also resistant to c-BSE, impairing its relevance for assessing the zoonotic potential of animal prion strains. In any case, an efficient transmission of these prion strains to primate, possibly in the presence of a weak cattle-to-primate species barrier, may be extrapolated from our results in the macaque model, which is strengthened by the transgenic model and the current absence of any argument for a zoonotic potential of prion strains derived from other ruminants (ovine or caprine classical or atypical scrapie, wild ruminant CWD).

 

2.3. Comparative Pathologies of the Diseases Induced by the Different Cattle Prions

 

The macaque inoculated with cattle-adapted TME showed widespread cortical spongiosis similar to that in both primates exposed to L-BSE (Figure 2). The spongiosis profile for these three animals was superimposable, with less pronounced lesions in the medulla and cerebellum in cattle TME-infected animal than in L-BSE animals (Figure 3). In the c-BSE-inoculated macaques, spongiosis profiles were different, with more discrete cortical spongiosis and lesions mainly affecting the thalamus, medulla oblongata and cerebellum. When we used a non-cattle (raccoon) TME source, a similar spongiosis profile was observed but with slight modifications (cortical lesions were less pronounced and pallidum and cerebellum were virtually spared).

 

Primates inoculated with L-BSE or cattle TME exhibited a similar diffuse laminar synaptic pattern of PrPres depositions (either fine and sandy or roughly granular) but no evidence of plaques, even when stained with thioflavine T (data not shown), whereas c-BSE-infected animals had weak diffuse synaptic labeling but multiple intensely-stained PrPres aggregates and characteristic plaques [21].

 

Figure 2. Histopathology and PrPres immunostaining. Spongiosis (A–D) and PrPres deposition (E–H) in frontal cortex in primates infected with cattle-adapted TME (A, E), L-BSE (B, F), classical BSE (C, G) or raccoon TME (D, H) (original magnification x200 for spongiosis and x400 for PrPres staining). Immunostaining of PrPres was performed with 3F4 monoclonal anti-PrP antibody after proteinase K treatment as previously described [21]. No staining was observed in the brain of control healthy primates (data not shown) under these conditions.

 

Figure 3. Spongiosis profiles in infected primates. Lesional profiles (based on spongiosis) in primates exposed to cattle-adapted TME (A) L-BSE (B), c-BSE (C) and raccoon TME (D) were defined according to the scoring and areas described by Parchi et al. [27]. Spongiosis profile of c-BSE primates is depicted as the mean among 5 primates exposed to c-BSE. Frontal Cortex (FC) ,Temporal Cortex (TC), Parietal Cortex (PC), Occipital Cortex (OC), Hippocampus (HI), Entorhinal Cortex (EC),Striatum (ST), Putamen (PUT), Pallidum (PAL), Thalamus (TH), Substantia Nigra (SN), Periventricular Gray (PG), Locus coeruleus (LC), Medulla (ME), Cerebellum (granules) (CB), Cerebellum (molecular layer) (CB), Purkinje cells (PK).

 

2.3. PrPres Detection: Strain Discrimination by Proteinase K Sensitivity and Antibody Reactivity

 

We previously demonstrated that the technique that we developed for typing and classifying prion strains in small ruminants might also be used to discriminate L-BSE from c-BSE in experimentally infected macaques [21]. Briefly, this technique is based on the strain-dependent threshold of removal of the octapeptides under controlled conditions of proteolysis, in which this N-terminal region is highly resistant to proteolysis for scrapie and sporadic CJD prions, but weakly resistant for c-BSE and undetectable for L-BSE.

 

Figure 4. Electrophoretic analysis and differential sensitivity to proteolysis of PrPres in various experimental prion diseases of primates and transgenic mice overexpressing human PrP. PrPres from brain homogenates (primates or transgenic mice Tg650 overexpressing human PrP experimentally infected with cattle-adapted TME, L-BSE or c-BSE) were purified with high concentrations of proteinase K, and detected with monoclonal antibodies recognizing the octapeptide region (Saf-32) or the core (Sha-31) of the protein. The membrane blotted with Saf-32 was overexposed compared to the membrane blotted with Sha-31.

 

Under these experimental conditions, PrPres in both primates and Tg650 exposed to cattle-adapted TME behaved like PrPres derived from corresponding animals infected with L-BSE [21] (Figure 4). A 19 kDa non-glycosylated band was observed with the anti-core antibody Sha-31, with an equal distribution between mono- and diglycosylated bands. With the anti-octapeptide antibody Saf-32, almost no immunoreactivity was detectable for these animals. In parallel, c-BSE infected animals exhibited the expected features, including a 20 kDa non glycosylated band with Sha-31, predominance of diglycosylated band and a weak immunoreactivity with Saf-32 (only observable when overexposing the membrane), suggesting that c-BSE related PrPres is more resistant to proteolysis than L-BSE- or TME-related PrPres (the macaque infected with raccoon TME exhibited glycophoretic profiles and resistance to proteolysis resistance similar to the macaque infected with cattle TME, data not shown). We previously described the biochemical similarities between PrPres derived from L-BSE infected macaque and cortical MM2 sporadic CJD: those observations suggest a link between these two uncommon prion phenotypes in a primate model (it is to note that such a link has not been observed in other models less relevant from the human situation as hamsters or transgenic mice overexpressing ovine PrP [28]). We speculate that a group of related animal prion strains (L-BSE, c-BSE and TME) would have a zoonotic potential and lead to prion diseases in humans with a type 2 PrPres molecular signature (and more specifically type 2B for vCJD).

 

Strain signatures were also assessed in bioassays in transgenic mice overexpressing bovine PrP (tg110). Those mice were intracerebrally inoculated with cattle-adapted TME, L-BSE or c-BSE isolates issued from cattle, macaque or tg650 recipients (vCJD samples were also included as controls) (Figure 1). All the inoculated mice developed a TSE, with similar incubation periods whatever the source (cattle, primate, Tg650 mice or human), but related to the original prion strain: mean periods ranged from 216 to 233 days for cattle-adapted TME and from 226 to 238 days for L-BSE, while c-BSE led to longer incubation periods ranging from 309 to 362 days. This biochemical strain typing protocol was adapted (preferential use of Bar-233 antibody for protein core detection) and applied to Tg110 mice (Figure 5). The respective features (size of non glycosylated band, proportion of glycosylated forms, resistance of octapeptide regions to proteolysis) that were observed in primates and Tg650 mice for each original prion strain (cattle TME, L-BSE or c-BSE) were also observed in this model, regardless of the host from which the prion originated.

 

Figure 5. Electrophoretic analysis and differential sensitivity to proteolysis of PrPres in various experimental prion diseases of transgenic mice overexpressing bovine PrP. Transgenic mice Tg110 overexpressing bovine PrP were inoculated with brain tissue from cattle, primate, or Tg650 mice experimentally infected with cattle-adapted TME, L-BSE or c-BSE, or brain tissue from a vCJD patient. The brains were homogenized and PrPres was purified with high concentrations of proteinase K, and detected with monoclonal antibodies that recognize either the octapeptide region (Saf-32) or the core (Bar-233) of the protein. The membrane blotted with Saf-32 was overexposed compared to the membrane blotted with Bar-233.

 

3. Experimental Section

 

3.1. Ethics Statement

 

Primates and mice were housed and handled in accordance with the European Directive 2010/63 related to animal protection and welfare in research, under the constant internal surveillance of veterinarians. Animals were handled under anesthesia to limit stress, and euthanasia was performed for ethical reasons when animals lost autonomy.

 

3.2. Experimental Animals

 

Captive-bred 2-5 year-old male cynomolgus macaques (Macaca fascicularis) were provided by Noveprim (Mauritius), checked for the absence of common primate pathogens before importation, and handled in accordance to national guidelines. Transgenic mice overexpressing human (tg650 [23]) or bovine (tg110 [29]) PrP were internally bred at CEA (Fontenay-aux-Roses, France). Animals housed in level-3 animal care facilities (agreement numbers A 92-032-02 for animal care facilities, 92-189 for animal experimentation) were regularly examined at least once a week.

 

3.3. Experimental Inoculations

 

The TME inocula were derived from a second passage in cattle (#A263, [7]) or the first passage from mink to raccoon (#R5-6, [30]). The L-BSE inoculum (mix of brainstem and thalamus) was derived from an asymptomatic 15 year-old Italian Piemontese cow (#1088, [10]), and the c-BSE inocula were derived from infected UK cattle. Macaques and mice were intracerebrally (i.c.) inoculated with 1% or 10% brain homogenates in a 5% glucose solution.

 

3.4. Neuropathology and Immunohistochemistry

 

Tissues were fixed in formalin 4% for histological examination. Neuropathology and immunohistochemical detection of protease-resistant prion protein (PrPres) were performed on brain sections as previously described [21].

 

3.4. PrPres Analysis

 

PrP was purified according to the TeSeE purification protocol (Bio-Rad), in adapted conditions of proteolysis for strain discrimination as previously described [21], using Bar-233, Sha-31 or Saf-32 antibodies.

 

4. Conclusions

 

We have shown that cattle-adapted TME is the third cattle prion strain (joining classical and L-type BSE) to be transmissible both to non-human primates and transgenic mice overexpressing human PrP. However, the successful transmission of raccoon TME to primate, inducing a disease with similar features as cattle TME, extends this notion to TME-related strains independent of host origin. Pathological, biochemical and bioassay investigations converged to demonstrate the similarity between cattle-adapted TME and L-BSE. Together with previous experiments performed in ovinized and bovinized transgenic mice and hamsters [8,9] indicating similarities between TME and L-BSE, the data support the hypothesis that L-BSE could be the origin of the TME outbreaks in North America and Europe during the mid-1900s. The corollary of this notion is the longstanding existence of atypical bovine prion cases in those countries during the same period, if not earlier. Although the risk of L-BSE for public health must be further assessed through studies using the oral route of exposure before drawing definitive conclusions, these data underline the importance of a potential zoonotic risk of L-BSE in the management of consumer protection, particularly in the context of the current relaxation of European policy with respect to BSE.

 

Acknowledgments

 

The authors acknowledge Health Canada and the NIAID-NIH PO1 AI 77774-01 “Pathogenesis, Transmission and Detection of Zoonotic Prion Diseases” for funding parts of those experiments. The authors thanks J.-L. Villotte and V. Beringue for their generous gift of transgenic mice overexpressing human PrP, as well as Christophe Durand, Onofrio Bevilacqua and Sébastien Jacquin for the excellent daily care they gave to the animals.

 

Conflict of Interest

 

The CEA owns a patent covering the BSE diagnostic tests commercialized by the company Bio-Rad.

 

References

 

SNIP...

 

 


 

 


 

 

 

 

>>>We previously described the biochemical similarities between PrPres derived from L-BSE infected macaque and cortical MM2 sporadic CJD: those observations suggest a link between these two uncommon prion phenotypes in a primate model (it is to note that such a link has not been observed in other models less relevant from the human situation as hamsters or transgenic mice overexpressing ovine PrP [28]). We speculate that a group of related animal prion strains (L-BSE, c-BSE and TME) would have a zoonotic potential and lead to prion diseases in humans with a type 2 PrPres molecular signature (and more specifically type 2B for vCJD)<<<

 

 

 

2003 Singeltary Submission to FDA ;

 

 

Asante/Collinge et al have major findings on sporadic CJD, why in the hell is this not making big news in the USA? ($$$) the fact that with the new findings from Collinge et al, that BSE transmission to the 129-methionine genotype can lead to an alternate phenotype which is indistinguishable from type 2 PrPSc, the commonest sporadic CJD, i only ponder how many of the sporadic CJDs in the USA are tied to this alternate phenotype? these new findings are very serious, and should have a major impact on the way sporadic CJDs are now treated as opposed to the vCJD that was thought to be the only TSE tied to ingesting beef, in the medical/surgical arena. these new findings should have a major impact on the way sporadic CJD is ignored, and should now be moved to the forefront of research as with vCJD/nvCJD. the USA has many TSEs, the USA lacks sufficient testing for TSEs in cattle, and the USA still refuses to rapid TSE test USA cattle in sufficient numbers to find, when the late Dr. Richard Marsh had proven that mink had gone down with a TSE (TME), from being fed on 95%+ downer cattle.

 


 


 

 

From: Terry S. Singeltary Sr. [flounder@wt.net]

 

Sent: Tuesday, July 29, 2003 1:03 PM

 


 

Cc: ggraber@cvm.fda.gov; Linda.Grassie@fda.gov; BSE-L

 

Subject: Docket No. 2003N-0312 Animal Feed Safety System [TSS SUBMISSION TO DOCKET 2003N-0312]

 

Greetings FDA,

 

my name is Terry S. Singeltary Sr., i lost my mother to hvCJD (Heidenhain Variant Creutzfeldt Jakob Disease).

 

i would kindly like to comment on the proposed HACCP method of detecting and or preventing TSEs in the human/animal feed supply.

 

it seems to me by implementing something that was designed for Astronauts instead of cattle, something that the GAO has already stated is terribly flawed (HACCP), i find it very disturbing to continue to insist on refusing to use rapid TSE TESTING in sufficient numbers to find TSEs, as with other Countries that they too once thought they were BSE free. for example, it took Italy 1 MILLION rapid TSE tests since 2001 to find 102 cases of BSE. THE USA has only tested 48,000 cattle in the 14 years of surveillance. there is documented proof that indeed the USA cattle have been infected with a TSE for decades, but the FDA/USDA and other USA Gov. agencies continue to conveniently ignore these findings. YOU must not ignore what Richard Marsh found. Plus, you must not ignore Asante/Collinge new findings that BSE transmission to the 129-methionine genotype can lead to an alternate phenotype that is indistinguishable from type 2 PrPSc, the commonest _sporadic_ CJD. The USA has been feeding ruminant by-products back to cattle, deer, elk and sheep for decades, and TSEs in these species have been recycled for feed for decades in the USA. The rendering process here in the USA will not kill this agent. to implement any HACCP over massive rapid TSE testing is only prolonging the inevitable, and will only allow the agent to spread further. it is simply a band-aid approach to something that needs a tourniquet...

 


 

 

 

From: Terry S. Singeltary Sr. [flounder9@verizon.net]

 

Sent: Monday, July 24, 2006 1:09 PM

 

To: FSIS RegulationsComments

 

Subject: [Docket No. FSIS-2006-0011] FSIS Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE)

 

Page 1 of 98

 

8/3/2006

 

Greetings FSIS,

 

I would kindly like to comment on the following ;

 

 


 

 

response to Singeltary et al ;

 


 

 


 

 

Monday, January 08, 2001 3:03 PM

 


 

 

 

A kind greetings from Bacliff, Texas !

 

I have often pondered if the whole damn mad cow follies started over here in the USA, and somehow, the USA shipped it over to the UK ?

 

It happened with S. Korea and CWD, via Canada. see ;

 

The disease was confirmed only in elk in the Republic of Korea in 2001, 2004 and 2005. Epidemiological investigations showed that CWD was introduced via importation of infected elk from Canada between 1994 and 1997.

 


 

 

 

but I still am not so sure that the mad cow follies did not start long ago right here in the USA i.e. Richard Marsh and deadstock downer cattle to those mink, and then the USA shipped it to hell and back. just pondering out loud here. ...tss

 

 

 

The exact same recipe for B.S.E. existed in the U.S. for years

 

and years. In reading over the Qualitative Analysis of BSE

 

Risk Factors-1, this is a 25 page report by the

 

USDA:APHIS:VS. It could have been done in one page. The

 

first page, fourth paragraph says it all;

 

"Similarities exist in the two countries usage of continuous

 

rendering technology and the lack of usage of solvents,

 

however, large differences still remain with other risk factors

 

which greatly reduce the potential risk at the national level."

 

Then, the next 24 pages tries to down-play the high risks of

 

B.S.E. in the U.S., with nothing more than the cattle to sheep

 

ratio count, and the geographical locations of herds and flocks.

 

That's all the evidence they can come up with, in the next 24

 

pages.

 

 Something else I find odd, page 16;

 

 "In the United Kingdom there is much concern for a specific

 

continuous rendering technology which uses lower

 

temperatures and accounts for 25 percent of total output. This

 

technology was _originally_ designed and imported from the

 

United States. However, the specific application in the

 

production process is _believed_ to be different in the two

 

countries."

 

 A few more factors to consider, page 15;

 

 "Figure 26 compares animal protein production for the two

 

countries. The calculations are based on slaughter numbers,

 

fallen stock estimates, and product yield coefficients. This

 

approach is used due to variation of up to 80 percent from

 

different reported sources. At 3.6 million tons, the United

 

States produces 8 times more animal rendered product than

 

the United Kingdom."

 

 "The risk of introducing the BSE agent through sheep meat and

 

bone meal is more acute in both relative and absolute terms in

 

the United Kingdom (Figures 27 and 28). Note that sheep

 

meat and bone meal accounts for 14 percent, or 61 thousand

 

tons, in the United Kingdom versus 0.6 percent or 22 thousand

 

tons in the United States. For sheep greater than 1 year, this is

 

less than one-tenth of one percent of the United States supply."

 

"The potential risk of amplification of the BSE agent through

 

cattle meat and bone meal is much greater in the United States

 

where it accounts for 59 percent of total product or almost 5

 

times more than the total amount of rendered product in the

 

United Kingdom."

 

 Considering, it would only take _one_ scrapie infected sheep

 

to contaminate the feed. Considering Scrapie has run rampant

 

in the U.S. for years, as of Aug. 1999, 950 scrapie infected

 

flocks. Also, Considering only one quarter spoonful of scrapie

 

infected material is lethal to a cow. Considering all this, the

 

sheep to cow ration is meaningless. As I said, it's 24 pages of

 

B.S.e.

 

To be continued...

 

Terry S. Singeltary Sr. P.O. Box 42 Bacliff, Texas USA

 

_____________________________________________________________________

 

 

 


 

 

snip...see full text ;

 

 

Monday, June 3, 2013

 

Unsuccessful oral transmission of scrapie from British sheep to cattle

 


 

 

Thursday, August 15, 2013

 

Stability properties of PrPSc from cattle with experimental transmissible spongiform encephalopathies: use of a rapid whole homogenate, protease-free assay

 


 

 

Sunday, July 21, 2013

 

Welsh Government and Food Standards Agency Wales Joint Public Consultation on the Proposed Transmissible Spongiform Encephalopathies (Wales) Regulations 2013 Singeltary Submission WG18417

 


 

 

 

Saturday, July 6, 2013

 

Small Ruminant Nor98 Prions Share Biochemical Features with Human Gerstmann-Sträussler-Scheinker Disease and Variably Protease-Sensitive Prionopathy

 

Research Article

 


 

 

 

Tuesday, July 21, 2009

 

Transmissible mink encephalopathy - review of the etiology

 


 

 

 

Saturday, December 01, 2007

 

Phenotypic Similarity of Transmissible Mink Encephalopathy in Cattle and L-type Bovine Spongiform Encephalopathy in a Mouse Model

 


 

 

 

Sunday, December 10, 2006

 

Transmissible Mink Encephalopathy TME

 


 


 

 

 

Thursday, March 29, 2012

 

atypical Nor-98 Scrapie has spread from coast to coast in the USA 2012

 

NIAA Annual Conference April 11-14, 2011San Antonio, Texas

 


 

 

 

Friday, July 26, 2013

 

Voluntary Scrapie Program USA UPDATE July 26, 2013 increase in FY 2013 is not statistically meaningful due to the sample size

 


 

 

 

Sunday, August 25, 2013

 

Prion2013 Chronic Wasting Disease CWD risk factors, humans, domestic cats, blood, and mother to offspring transmission

 


 

 

 

Friday, August 16, 2013

 

*** Creutzfeldt-Jakob disease (CJD) biannual update August 2013 U.K. and Contaminated blood products induce a highly atypical prion disease devoid of PrPres in primates

 


 

 

 

Sunday, August 11, 2013

 

Creutzfeldt-Jakob Disease CJD cases rising North America updated report August 2013

 

*** Creutzfeldt-Jakob Disease CJD cases rising North America with Canada seeing an extreme increase of 48% between 2008 and 2010

 


 

 

 

 

TSS